7 Undervalued Blue-Chip Stocks to Buy for June

InvestorPlace2022-05-27

These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

195

Report

Comment（49）

Quicklearner
·2022-05-27
Which is the one?
Reply
Like
Report
Huat1333
·2022-05-27
Which to pick [What] [What] [What]
Reply
1
Report
Huat1333
·2022-05-27
Wow..which one tp pick [Speechless] [Speechless] [Speechless]
Reply
1
Report
HENRYCSC
·2022-05-27
Thanks
Reply
Like
Report
JY1980
·2022-05-27
Hi
Reply
3
Report
FT585
·2022-05-27
Like
Reply
3
Report
Ming Shao
·2022-05-27
Microsoft is my choice among all simply because their software revenue is on a subscription model. Revenue is recurring.
Reply
1
Report
JeremyEe
·2022-05-27
9i
Reply
2
Report
JeremyEe
·2022-05-27
Hi
Reply
2
Report
AndyChoo
·2022-05-27
Micron is my top pick
Reply
1
Report
Moneyong
·2022-05-27
Like
Reply
3
Report
Nana_seven
·2022-05-27
Pls like
Reply
5
Report
xupper22
·2022-05-27
Invest in Pfizer only because it's one of the biggest names in this space. If you are investing in Pfizer because of covid, your baseline mindset is wrong. Pfizer in covid is corruption, we still have no idea if they will be punished or not - extreme volatility. However, their other products and future corruption attempts may prove profitable once again.
Reply
12
Report
xJAxAx
·2022-05-27
Like pls
Reply
2
Report
Payneri
·2022-05-27
Interesting view
Reply
1
Report
Chris Tan
·2022-05-27
🏃‍♂️🏃‍♂️🏃‍♂️
Reply
1
Report
Verine
·2022-05-27
Nice
Reply
2
Report
gamerxyj
·2022-05-27
Can consider 👍
Reply
1
Report
ming22
·2022-05-27
Good, time to dca
Reply
3
Report
HL Chua
·2022-05-27
All expensive stocks to me
Reply
5
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1154795776?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-05-27 13:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1154795776","market":"us","top_or_hot":-1,"title":"7 Undervalued Blue-Chip Stocks to Buy for June","media":"InvestorPlace","content":"<div>\nThese undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities ...\n\n<a href=\"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Undervalued Blue-Chip Stocks to Buy for June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Undervalued Blue-Chip Stocks to Buy for June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-27 13:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nThese undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities ...\n\n<a href=\"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PFE","symbol_name":"辉瑞","start_time":0,"source_url":"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/","article_id":"1154795776","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1154795776","pubTimestamp":1653628057,"sourceInfo":{"source_id":"lsy1606302653667","name":"InvestorPlace"},"weMediaInfo":null,"summary":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"PFE":"辉瑞","AIG":"美国国际集团","MU":"美光科技","MSFT":"微软","AA":"美国铝业","MMM":"3M","NTR":"Nutrien Ltd."},"translate_title":"6月买入7只低估蓝筹股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AA":0.9,"AIG":0.9,"MMM":0.9,"MSFT":0.9,"MU":0.9,"NTR":0.9,"PFE":0.9},"content_text":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities giant.Nutrien: The undervalued Canadian firm is vital to food production.American International Group: AIG’s upside is attractive and its staid dividend smooths current volatility.3M: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.Microsoft: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.Pfizer: Vaccine sales will fuel future growth, making Pfizer noteworthy.With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.MicronSource: Charles Knowles / Shutterstock.comMicron is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.AlcoaSource: Daniel J. Macy / Shutterstock.comAlcoa produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.NutrienSource: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like Nutrien, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.American International GroupSource: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.3MSource: r.classen / Shutterstock.com3M produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.MicrosoftSource: The Art of Pics / Shutterstock.comWhen 2022 began, Microsoft stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.PfizerSource: photobyphm / Shutterstock.comPfizer received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9025154525,"gmtCreate":1653645555667,"gmtModify":1676535320370,"author":{"id":"3574936639222161","authorId":"3574936639222161","name":"Quicklearner","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":1,"idStr":"3574936639222161","authorIdStr":"3574936639222161"},"htmlText":"Which is the one?&nbsp;","listText":"Which is the one?&nbsp;","text":"Which is the one?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9025154525","repostId":1154795776,"repostType":4,"repost":{"id":"1154795776","pubTimestamp":1653628057,"share":"https://ttm.financial/m/news/1154795776?lang=&edition=fundamental","pubTime":"2022-05-27 13:07","market":"us","language":"en","title":"7 Undervalued Blue-Chip Stocks to Buy for June","url":"https://stock-news.laohu8.com/highlight/detail?id=1154795776","media":"InvestorPlace","summary":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock","content":"<html><head></head><body>These undervalued blue-chip stocks possess excellent long-term potential.<ul><li><a href=\"https://laohu8.com/S/MU\">Micron</a>: Semiconductor stock that blends growth and low valuation.</li><li><a href=\"https://laohu8.com/S/AA\">Alcoa</a>: Net income growth bodes very well for the commodities giant.</li><li><a href=\"https://laohu8.com/S/NTR\">Nutrien</a>: The undervalued Canadian firm is vital to food production.</li><li><a href=\"https://laohu8.com/S/AIG\">American International Group</a>: AIG’s upside is attractive and its staid dividend smooths current volatility.</li><li><a href=\"https://laohu8.com/S/MMM\">3M</a>: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.</li><li><a href=\"https://laohu8.com/S/MSFT\">Microsoft</a>: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.</li><li><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>: Vaccine sales will fuel future growth, making Pfizer noteworthy.</li></ul>With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.<a href=\"https://laohu8.com/S/MU\">Micron</a><img src=\"https://static.tigerbbs.com/d789740a0d55698fce2eaa27ff334fcb\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Charles Knowles / Shutterstock.com<a href=\"https://laohu8.com/S/MU\">Micron</a> is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.<a href=\"https://laohu8.com/S/AA\">Alcoa</a><img src=\"https://static.tigerbbs.com/345c732c89a6bd214adff72fe56d3249\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Daniel J. Macy / Shutterstock.com<a href=\"https://laohu8.com/S/AA\">Alcoa</a> produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.<a href=\"https://laohu8.com/S/NTR\">Nutrien</a><img src=\"https://static.tigerbbs.com/cf261f41b67b978b2bccc50b86f9619b\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like <a href=\"https://laohu8.com/S/NTR\">Nutrien</a>, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.<a href=\"https://laohu8.com/S/AIG\">American International Group</a><img src=\"https://static.tigerbbs.com/4fbf6ee441b7aaaccd4fbe0cf78bfd2a\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.<a href=\"https://laohu8.com/S/MMM\">3M</a><img src=\"https://static.tigerbbs.com/dcfdc62e0b1977b35e871a578f6f8388\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: r.classen / Shutterstock.com<a href=\"https://laohu8.com/S/MMM\">3M</a> produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.<a href=\"https://laohu8.com/S/MSFT\">Microsoft</a><img src=\"https://static.tigerbbs.com/998767af9244c24d2eca1a6c74ee6b60\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: The Art of Pics / Shutterstock.comWhen 2022 began, <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.<a href=\"https://laohu8.com/S/PFE\">Pfizer</a><img src=\"https://static.tigerbbs.com/24582c18e5505b72fa27f4466b6dc4db\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: photobyphm / Shutterstock.com<a href=\"https://laohu8.com/S/PFE\">Pfizer</a> received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Undervalued Blue-Chip Stocks to Buy for June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Undervalued Blue-Chip Stocks to Buy for June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-27 13:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nThese undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities ...\n\n<a href=\"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NTR":"Nutrien Ltd.","MSFT":"微软","MMM":"3M","AIG":"美国国际集团","MU":"美光科技","AA":"美国铝业"},"source_url":"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154795776","content_text":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities giant.Nutrien: The undervalued Canadian firm is vital to food production.American International Group: AIG’s upside is attractive and its staid dividend smooths current volatility.3M: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.Microsoft: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.Pfizer: Vaccine sales will fuel future growth, making Pfizer noteworthy.With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.MicronSource: Charles Knowles / Shutterstock.comMicron is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.AlcoaSource: Daniel J. Macy / Shutterstock.comAlcoa produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.NutrienSource: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like Nutrien, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.American International GroupSource: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.3MSource: r.classen / Shutterstock.com3M produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.MicrosoftSource: The Art of Pics / Shutterstock.comWhen 2022 began, Microsoft stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.PfizerSource: photobyphm / Shutterstock.comPfizer received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9025126752,"gmtCreate":1653642281276,"gmtModify":1676535319990,"author":{"id":"3559014783889591","authorId":"3559014783889591","name":"Huat1333","avatar":"https://community-static.tradeup.com/news/a4c138e1ce20043d7996468a91a225ac","vip":1,"hat":"https://static.tigerbbs.com/50a4c8d97279fa9f8f1fa9749a6bdff4","crmLevel":7,"crmLevelSwitch":1,"idStr":"3559014783889591","authorIdStr":"3559014783889591"},"htmlText":"Which to pick&nbsp;[What]&nbsp;[What]&nbsp;[What]&nbsp;","listText":"Which to pick&nbsp;[What]&nbsp;[What]&nbsp;[What]&nbsp;","text":"Which to pick [What] [What] [What]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9025126752","repostId":1154795776,"repostType":4,"repost":{"id":"1154795776","pubTimestamp":1653628057,"share":"https://ttm.financial/m/news/1154795776?lang=&edition=fundamental","pubTime":"2022-05-27 13:07","market":"us","language":"en","title":"7 Undervalued Blue-Chip Stocks to Buy for June","url":"https://stock-news.laohu8.com/highlight/detail?id=1154795776","media":"InvestorPlace","summary":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock","content":"<html><head></head><body>These undervalued blue-chip stocks possess excellent long-term potential.<ul><li><a href=\"https://laohu8.com/S/MU\">Micron</a>: Semiconductor stock that blends growth and low valuation.</li><li><a href=\"https://laohu8.com/S/AA\">Alcoa</a>: Net income growth bodes very well for the commodities giant.</li><li><a href=\"https://laohu8.com/S/NTR\">Nutrien</a>: The undervalued Canadian firm is vital to food production.</li><li><a href=\"https://laohu8.com/S/AIG\">American International Group</a>: AIG’s upside is attractive and its staid dividend smooths current volatility.</li><li><a href=\"https://laohu8.com/S/MMM\">3M</a>: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.</li><li><a href=\"https://laohu8.com/S/MSFT\">Microsoft</a>: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.</li><li><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>: Vaccine sales will fuel future growth, making Pfizer noteworthy.</li></ul>With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.<a href=\"https://laohu8.com/S/MU\">Micron</a><img src=\"https://static.tigerbbs.com/d789740a0d55698fce2eaa27ff334fcb\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Charles Knowles / Shutterstock.com<a href=\"https://laohu8.com/S/MU\">Micron</a> is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.<a href=\"https://laohu8.com/S/AA\">Alcoa</a><img src=\"https://static.tigerbbs.com/345c732c89a6bd214adff72fe56d3249\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Daniel J. Macy / Shutterstock.com<a href=\"https://laohu8.com/S/AA\">Alcoa</a> produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.<a href=\"https://laohu8.com/S/NTR\">Nutrien</a><img src=\"https://static.tigerbbs.com/cf261f41b67b978b2bccc50b86f9619b\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like <a href=\"https://laohu8.com/S/NTR\">Nutrien</a>, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.<a href=\"https://laohu8.com/S/AIG\">American International Group</a><img src=\"https://static.tigerbbs.com/4fbf6ee441b7aaaccd4fbe0cf78bfd2a\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.<a href=\"https://laohu8.com/S/MMM\">3M</a><img src=\"https://static.tigerbbs.com/dcfdc62e0b1977b35e871a578f6f8388\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: r.classen / Shutterstock.com<a href=\"https://laohu8.com/S/MMM\">3M</a> produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.<a href=\"https://laohu8.com/S/MSFT\">Microsoft</a><img src=\"https://static.tigerbbs.com/998767af9244c24d2eca1a6c74ee6b60\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: The Art of Pics / Shutterstock.comWhen 2022 began, <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.<a href=\"https://laohu8.com/S/PFE\">Pfizer</a><img src=\"https://static.tigerbbs.com/24582c18e5505b72fa27f4466b6dc4db\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: photobyphm / Shutterstock.com<a href=\"https://laohu8.com/S/PFE\">Pfizer</a> received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Undervalued Blue-Chip Stocks to Buy for June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Undervalued Blue-Chip Stocks to Buy for June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-27 13:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nThese undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities ...\n\n<a href=\"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NTR":"Nutrien Ltd.","MSFT":"微软","MMM":"3M","AIG":"美国国际集团","MU":"美光科技","AA":"美国铝业"},"source_url":"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154795776","content_text":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities giant.Nutrien: The undervalued Canadian firm is vital to food production.American International Group: AIG’s upside is attractive and its staid dividend smooths current volatility.3M: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.Microsoft: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.Pfizer: Vaccine sales will fuel future growth, making Pfizer noteworthy.With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.MicronSource: Charles Knowles / Shutterstock.comMicron is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.AlcoaSource: Daniel J. Macy / Shutterstock.comAlcoa produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.NutrienSource: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like Nutrien, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.American International GroupSource: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.3MSource: r.classen / Shutterstock.com3M produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.MicrosoftSource: The Art of Pics / Shutterstock.comWhen 2022 began, Microsoft stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.PfizerSource: photobyphm / Shutterstock.comPfizer received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9025126878,"gmtCreate":1653642240394,"gmtModify":1676535319974,"author":{"id":"3559014783889591","authorId":"3559014783889591","name":"Huat1333","avatar":"https://community-static.tradeup.com/news/a4c138e1ce20043d7996468a91a225ac","vip":1,"hat":"https://static.tigerbbs.com/50a4c8d97279fa9f8f1fa9749a6bdff4","crmLevel":7,"crmLevelSwitch":1,"idStr":"3559014783889591","authorIdStr":"3559014783889591"},"htmlText":"Wow..which one tp pick&nbsp;[Speechless]&nbsp;[Speechless]&nbsp;[Speechless]&nbsp;","listText":"Wow..which one tp pick&nbsp;[Speechless]&nbsp;[Speechless]&nbsp;[Speechless]&nbsp;","text":"Wow..which one tp pick [Speechless] [Speechless] [Speechless]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9025126878","repostId":1154795776,"repostType":4,"repost":{"id":"1154795776","pubTimestamp":1653628057,"share":"https://ttm.financial/m/news/1154795776?lang=&edition=fundamental","pubTime":"2022-05-27 13:07","market":"us","language":"en","title":"7 Undervalued Blue-Chip Stocks to Buy for June","url":"https://stock-news.laohu8.com/highlight/detail?id=1154795776","media":"InvestorPlace","summary":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock","content":"<html><head></head><body>These undervalued blue-chip stocks possess excellent long-term potential.<ul><li><a href=\"https://laohu8.com/S/MU\">Micron</a>: Semiconductor stock that blends growth and low valuation.</li><li><a href=\"https://laohu8.com/S/AA\">Alcoa</a>: Net income growth bodes very well for the commodities giant.</li><li><a href=\"https://laohu8.com/S/NTR\">Nutrien</a>: The undervalued Canadian firm is vital to food production.</li><li><a href=\"https://laohu8.com/S/AIG\">American International Group</a>: AIG’s upside is attractive and its staid dividend smooths current volatility.</li><li><a href=\"https://laohu8.com/S/MMM\">3M</a>: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.</li><li><a href=\"https://laohu8.com/S/MSFT\">Microsoft</a>: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.</li><li><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>: Vaccine sales will fuel future growth, making Pfizer noteworthy.</li></ul>With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.<a href=\"https://laohu8.com/S/MU\">Micron</a><img src=\"https://static.tigerbbs.com/d789740a0d55698fce2eaa27ff334fcb\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Charles Knowles / Shutterstock.com<a href=\"https://laohu8.com/S/MU\">Micron</a> is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.<a href=\"https://laohu8.com/S/AA\">Alcoa</a><img src=\"https://static.tigerbbs.com/345c732c89a6bd214adff72fe56d3249\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Daniel J. Macy / Shutterstock.com<a href=\"https://laohu8.com/S/AA\">Alcoa</a> produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.<a href=\"https://laohu8.com/S/NTR\">Nutrien</a><img src=\"https://static.tigerbbs.com/cf261f41b67b978b2bccc50b86f9619b\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like <a href=\"https://laohu8.com/S/NTR\">Nutrien</a>, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.<a href=\"https://laohu8.com/S/AIG\">American International Group</a><img src=\"https://static.tigerbbs.com/4fbf6ee441b7aaaccd4fbe0cf78bfd2a\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.<a href=\"https://laohu8.com/S/MMM\">3M</a><img src=\"https://static.tigerbbs.com/dcfdc62e0b1977b35e871a578f6f8388\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: r.classen / Shutterstock.com<a href=\"https://laohu8.com/S/MMM\">3M</a> produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.<a href=\"https://laohu8.com/S/MSFT\">Microsoft</a><img src=\"https://static.tigerbbs.com/998767af9244c24d2eca1a6c74ee6b60\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: The Art of Pics / Shutterstock.comWhen 2022 began, <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.<a href=\"https://laohu8.com/S/PFE\">Pfizer</a><img src=\"https://static.tigerbbs.com/24582c18e5505b72fa27f4466b6dc4db\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: photobyphm / Shutterstock.com<a href=\"https://laohu8.com/S/PFE\">Pfizer</a> received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Undervalued Blue-Chip Stocks to Buy for June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Undervalued Blue-Chip Stocks to Buy for June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-27 13:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nThese undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities ...\n\n<a href=\"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NTR":"Nutrien Ltd.","MSFT":"微软","MMM":"3M","AIG":"美国国际集团","MU":"美光科技","AA":"美国铝业"},"source_url":"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154795776","content_text":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities giant.Nutrien: The undervalued Canadian firm is vital to food production.American International Group: AIG’s upside is attractive and its staid dividend smooths current volatility.3M: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.Microsoft: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.Pfizer: Vaccine sales will fuel future growth, making Pfizer noteworthy.With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.MicronSource: Charles Knowles / Shutterstock.comMicron is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.AlcoaSource: Daniel J. Macy / Shutterstock.comAlcoa produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.NutrienSource: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like Nutrien, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.American International GroupSource: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.3MSource: r.classen / Shutterstock.com3M produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.MicrosoftSource: The Art of Pics / Shutterstock.comWhen 2022 began, Microsoft stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.PfizerSource: photobyphm / Shutterstock.comPfizer received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9025168714,"gmtCreate":1653640375838,"gmtModify":1676535319725,"author":{"id":"3575091428590185","authorId":"3575091428590185","name":"HENRYCSC","avatar":"https://static.tigerbbs.com/6d47a6dec25b21dc547a5b982674c499","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3575091428590185","authorIdStr":"3575091428590185"},"htmlText":"Thanks&nbsp;","listText":"Thanks&nbsp;","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9025168714","repostId":1154795776,"repostType":4,"repost":{"id":"1154795776","pubTimestamp":1653628057,"share":"https://ttm.financial/m/news/1154795776?lang=&edition=fundamental","pubTime":"2022-05-27 13:07","market":"us","language":"en","title":"7 Undervalued Blue-Chip Stocks to Buy for June","url":"https://stock-news.laohu8.com/highlight/detail?id=1154795776","media":"InvestorPlace","summary":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock","content":"<html><head></head><body>These undervalued blue-chip stocks possess excellent long-term potential.<ul><li><a href=\"https://laohu8.com/S/MU\">Micron</a>: Semiconductor stock that blends growth and low valuation.</li><li><a href=\"https://laohu8.com/S/AA\">Alcoa</a>: Net income growth bodes very well for the commodities giant.</li><li><a href=\"https://laohu8.com/S/NTR\">Nutrien</a>: The undervalued Canadian firm is vital to food production.</li><li><a href=\"https://laohu8.com/S/AIG\">American International Group</a>: AIG’s upside is attractive and its staid dividend smooths current volatility.</li><li><a href=\"https://laohu8.com/S/MMM\">3M</a>: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.</li><li><a href=\"https://laohu8.com/S/MSFT\">Microsoft</a>: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.</li><li><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>: Vaccine sales will fuel future growth, making Pfizer noteworthy.</li></ul>With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.<a href=\"https://laohu8.com/S/MU\">Micron</a><img src=\"https://static.tigerbbs.com/d789740a0d55698fce2eaa27ff334fcb\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Charles Knowles / Shutterstock.com<a href=\"https://laohu8.com/S/MU\">Micron</a> is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.<a href=\"https://laohu8.com/S/AA\">Alcoa</a><img src=\"https://static.tigerbbs.com/345c732c89a6bd214adff72fe56d3249\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Daniel J. Macy / Shutterstock.com<a href=\"https://laohu8.com/S/AA\">Alcoa</a> produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.<a href=\"https://laohu8.com/S/NTR\">Nutrien</a><img src=\"https://static.tigerbbs.com/cf261f41b67b978b2bccc50b86f9619b\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like <a href=\"https://laohu8.com/S/NTR\">Nutrien</a>, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.<a href=\"https://laohu8.com/S/AIG\">American International Group</a><img src=\"https://static.tigerbbs.com/4fbf6ee441b7aaaccd4fbe0cf78bfd2a\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.<a href=\"https://laohu8.com/S/MMM\">3M</a><img src=\"https://static.tigerbbs.com/dcfdc62e0b1977b35e871a578f6f8388\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: r.classen / Shutterstock.com<a href=\"https://laohu8.com/S/MMM\">3M</a> produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.<a href=\"https://laohu8.com/S/MSFT\">Microsoft</a><img src=\"https://static.tigerbbs.com/998767af9244c24d2eca1a6c74ee6b60\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: The Art of Pics / Shutterstock.comWhen 2022 began, <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.<a href=\"https://laohu8.com/S/PFE\">Pfizer</a><img src=\"https://static.tigerbbs.com/24582c18e5505b72fa27f4466b6dc4db\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: photobyphm / Shutterstock.com<a href=\"https://laohu8.com/S/PFE\">Pfizer</a> received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Undervalued Blue-Chip Stocks to Buy for June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Undervalued Blue-Chip Stocks to Buy for June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-27 13:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nThese undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities ...\n\n<a href=\"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NTR":"Nutrien Ltd.","MSFT":"微软","MMM":"3M","AIG":"美国国际集团","MU":"美光科技","AA":"美国铝业"},"source_url":"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154795776","content_text":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities giant.Nutrien: The undervalued Canadian firm is vital to food production.American International Group: AIG’s upside is attractive and its staid dividend smooths current volatility.3M: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.Microsoft: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.Pfizer: Vaccine sales will fuel future growth, making Pfizer noteworthy.With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.MicronSource: Charles Knowles / Shutterstock.comMicron is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.AlcoaSource: Daniel J. Macy / Shutterstock.comAlcoa produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.NutrienSource: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like Nutrien, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.American International GroupSource: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.3MSource: r.classen / Shutterstock.com3M produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.MicrosoftSource: The Art of Pics / Shutterstock.comWhen 2022 began, Microsoft stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.PfizerSource: photobyphm / Shutterstock.comPfizer received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9025161673,"gmtCreate":1653640147792,"gmtModify":1676535319695,"author":{"id":"3582667225966897","authorId":"3582667225966897","name":"JY1980","avatar":"https://static.tigerbbs.com/c6f123e82a9a8b2f55744c343c13bbdc","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3582667225966897","authorIdStr":"3582667225966897"},"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9025161673","repostId":1154795776,"repostType":4,"repost":{"id":"1154795776","pubTimestamp":1653628057,"share":"https://ttm.financial/m/news/1154795776?lang=&edition=fundamental","pubTime":"2022-05-27 13:07","market":"us","language":"en","title":"7 Undervalued Blue-Chip Stocks to Buy for June","url":"https://stock-news.laohu8.com/highlight/detail?id=1154795776","media":"InvestorPlace","summary":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock","content":"<html><head></head><body>These undervalued blue-chip stocks possess excellent long-term potential.<ul><li><a href=\"https://laohu8.com/S/MU\">Micron</a>: Semiconductor stock that blends growth and low valuation.</li><li><a href=\"https://laohu8.com/S/AA\">Alcoa</a>: Net income growth bodes very well for the commodities giant.</li><li><a href=\"https://laohu8.com/S/NTR\">Nutrien</a>: The undervalued Canadian firm is vital to food production.</li><li><a href=\"https://laohu8.com/S/AIG\">American International Group</a>: AIG’s upside is attractive and its staid dividend smooths current volatility.</li><li><a href=\"https://laohu8.com/S/MMM\">3M</a>: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.</li><li><a href=\"https://laohu8.com/S/MSFT\">Microsoft</a>: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.</li><li><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>: Vaccine sales will fuel future growth, making Pfizer noteworthy.</li></ul>With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.<a href=\"https://laohu8.com/S/MU\">Micron</a><img src=\"https://static.tigerbbs.com/d789740a0d55698fce2eaa27ff334fcb\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Charles Knowles / Shutterstock.com<a href=\"https://laohu8.com/S/MU\">Micron</a> is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.<a href=\"https://laohu8.com/S/AA\">Alcoa</a><img src=\"https://static.tigerbbs.com/345c732c89a6bd214adff72fe56d3249\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Daniel J. Macy / Shutterstock.com<a href=\"https://laohu8.com/S/AA\">Alcoa</a> produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.<a href=\"https://laohu8.com/S/NTR\">Nutrien</a><img src=\"https://static.tigerbbs.com/cf261f41b67b978b2bccc50b86f9619b\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like <a href=\"https://laohu8.com/S/NTR\">Nutrien</a>, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.<a href=\"https://laohu8.com/S/AIG\">American International Group</a><img src=\"https://static.tigerbbs.com/4fbf6ee441b7aaaccd4fbe0cf78bfd2a\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.<a href=\"https://laohu8.com/S/MMM\">3M</a><img src=\"https://static.tigerbbs.com/dcfdc62e0b1977b35e871a578f6f8388\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: r.classen / Shutterstock.com<a href=\"https://laohu8.com/S/MMM\">3M</a> produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.<a href=\"https://laohu8.com/S/MSFT\">Microsoft</a><img src=\"https://static.tigerbbs.com/998767af9244c24d2eca1a6c74ee6b60\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: The Art of Pics / Shutterstock.comWhen 2022 began, <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.<a href=\"https://laohu8.com/S/PFE\">Pfizer</a><img src=\"https://static.tigerbbs.com/24582c18e5505b72fa27f4466b6dc4db\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: photobyphm / Shutterstock.com<a href=\"https://laohu8.com/S/PFE\">Pfizer</a> received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Undervalued Blue-Chip Stocks to Buy for June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Undervalued Blue-Chip Stocks to Buy for June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-27 13:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nThese undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities ...\n\n<a href=\"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NTR":"Nutrien Ltd.","MSFT":"微软","MMM":"3M","AIG":"美国国际集团","MU":"美光科技","AA":"美国铝业"},"source_url":"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154795776","content_text":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities giant.Nutrien: The undervalued Canadian firm is vital to food production.American International Group: AIG’s upside is attractive and its staid dividend smooths current volatility.3M: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.Microsoft: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.Pfizer: Vaccine sales will fuel future growth, making Pfizer noteworthy.With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.MicronSource: Charles Knowles / Shutterstock.comMicron is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.AlcoaSource: Daniel J. Macy / Shutterstock.comAlcoa produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.NutrienSource: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like Nutrien, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.American International GroupSource: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.3MSource: r.classen / Shutterstock.com3M produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.MicrosoftSource: The Art of Pics / Shutterstock.comWhen 2022 began, Microsoft stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.PfizerSource: photobyphm / Shutterstock.comPfizer received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9025169068,"gmtCreate":1653639845754,"gmtModify":1676535319635,"author":{"id":"3562726241279787","authorId":"3562726241279787","name":"FT585","avatar":"https://static.tigerbbs.com/734b50619b12425294cb4715814bdedb","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3562726241279787","authorIdStr":"3562726241279787"},"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9025169068","repostId":1154795776,"repostType":4,"repost":{"id":"1154795776","pubTimestamp":1653628057,"share":"https://ttm.financial/m/news/1154795776?lang=&edition=fundamental","pubTime":"2022-05-27 13:07","market":"us","language":"en","title":"7 Undervalued Blue-Chip Stocks to Buy for June","url":"https://stock-news.laohu8.com/highlight/detail?id=1154795776","media":"InvestorPlace","summary":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock","content":"<html><head></head><body>These undervalued blue-chip stocks possess excellent long-term potential.<ul><li><a href=\"https://laohu8.com/S/MU\">Micron</a>: Semiconductor stock that blends growth and low valuation.</li><li><a href=\"https://laohu8.com/S/AA\">Alcoa</a>: Net income growth bodes very well for the commodities giant.</li><li><a href=\"https://laohu8.com/S/NTR\">Nutrien</a>: The undervalued Canadian firm is vital to food production.</li><li><a href=\"https://laohu8.com/S/AIG\">American International Group</a>: AIG’s upside is attractive and its staid dividend smooths current volatility.</li><li><a href=\"https://laohu8.com/S/MMM\">3M</a>: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.</li><li><a href=\"https://laohu8.com/S/MSFT\">Microsoft</a>: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.</li><li><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>: Vaccine sales will fuel future growth, making Pfizer noteworthy.</li></ul>With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.<a href=\"https://laohu8.com/S/MU\">Micron</a><img src=\"https://static.tigerbbs.com/d789740a0d55698fce2eaa27ff334fcb\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Charles Knowles / Shutterstock.com<a href=\"https://laohu8.com/S/MU\">Micron</a> is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.<a href=\"https://laohu8.com/S/AA\">Alcoa</a><img src=\"https://static.tigerbbs.com/345c732c89a6bd214adff72fe56d3249\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Daniel J. Macy / Shutterstock.com<a href=\"https://laohu8.com/S/AA\">Alcoa</a> produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.<a href=\"https://laohu8.com/S/NTR\">Nutrien</a><img src=\"https://static.tigerbbs.com/cf261f41b67b978b2bccc50b86f9619b\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like <a href=\"https://laohu8.com/S/NTR\">Nutrien</a>, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.<a href=\"https://laohu8.com/S/AIG\">American International Group</a><img src=\"https://static.tigerbbs.com/4fbf6ee441b7aaaccd4fbe0cf78bfd2a\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.<a href=\"https://laohu8.com/S/MMM\">3M</a><img src=\"https://static.tigerbbs.com/dcfdc62e0b1977b35e871a578f6f8388\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: r.classen / Shutterstock.com<a href=\"https://laohu8.com/S/MMM\">3M</a> produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.<a href=\"https://laohu8.com/S/MSFT\">Microsoft</a><img src=\"https://static.tigerbbs.com/998767af9244c24d2eca1a6c74ee6b60\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: The Art of Pics / Shutterstock.comWhen 2022 began, <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.<a href=\"https://laohu8.com/S/PFE\">Pfizer</a><img src=\"https://static.tigerbbs.com/24582c18e5505b72fa27f4466b6dc4db\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: photobyphm / Shutterstock.com<a href=\"https://laohu8.com/S/PFE\">Pfizer</a> received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Undervalued Blue-Chip Stocks to Buy for June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Undervalued Blue-Chip Stocks to Buy for June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-27 13:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nThese undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities ...\n\n<a href=\"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NTR":"Nutrien Ltd.","MSFT":"微软","MMM":"3M","AIG":"美国国际集团","MU":"美光科技","AA":"美国铝业"},"source_url":"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154795776","content_text":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities giant.Nutrien: The undervalued Canadian firm is vital to food production.American International Group: AIG’s upside is attractive and its staid dividend smooths current volatility.3M: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.Microsoft: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.Pfizer: Vaccine sales will fuel future growth, making Pfizer noteworthy.With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.MicronSource: Charles Knowles / Shutterstock.comMicron is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.AlcoaSource: Daniel J. Macy / Shutterstock.comAlcoa produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.NutrienSource: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like Nutrien, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.American International GroupSource: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.3MSource: r.classen / Shutterstock.com3M produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.MicrosoftSource: The Art of Pics / Shutterstock.comWhen 2022 began, Microsoft stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.PfizerSource: photobyphm / Shutterstock.comPfizer received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9025184602,"gmtCreate":1653639354506,"gmtModify":1676535319566,"author":{"id":"4101649280417420","authorId":"4101649280417420","name":"Ming Shao","avatar":"https://static.tigerbbs.com/a69b737c538cc3c7fe89b03db59e071e","vip":1,"crmLevel":2,"crmLevelSwitch":1,"idStr":"4101649280417420","authorIdStr":"4101649280417420"},"htmlText":"Microsoft is my choice among all simply because their software revenue is on a subscription model. Revenue is&nbsp;recurring.&nbsp;&nbsp;","listText":"Microsoft is my choice among all simply because their software revenue is on a subscription model. Revenue is&nbsp;recurring.&nbsp;&nbsp;","text":"Microsoft is my choice among all simply because their software revenue is on a subscription model. Revenue is recurring.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9025184602","repostId":1154795776,"repostType":4,"repost":{"id":"1154795776","pubTimestamp":1653628057,"share":"https://ttm.financial/m/news/1154795776?lang=&edition=fundamental","pubTime":"2022-05-27 13:07","market":"us","language":"en","title":"7 Undervalued Blue-Chip Stocks to Buy for June","url":"https://stock-news.laohu8.com/highlight/detail?id=1154795776","media":"InvestorPlace","summary":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock","content":"<html><head></head><body>These undervalued blue-chip stocks possess excellent long-term potential.<ul><li><a href=\"https://laohu8.com/S/MU\">Micron</a>: Semiconductor stock that blends growth and low valuation.</li><li><a href=\"https://laohu8.com/S/AA\">Alcoa</a>: Net income growth bodes very well for the commodities giant.</li><li><a href=\"https://laohu8.com/S/NTR\">Nutrien</a>: The undervalued Canadian firm is vital to food production.</li><li><a href=\"https://laohu8.com/S/AIG\">American International Group</a>: AIG’s upside is attractive and its staid dividend smooths current volatility.</li><li><a href=\"https://laohu8.com/S/MMM\">3M</a>: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.</li><li><a href=\"https://laohu8.com/S/MSFT\">Microsoft</a>: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.</li><li><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>: Vaccine sales will fuel future growth, making Pfizer noteworthy.</li></ul>With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.<a href=\"https://laohu8.com/S/MU\">Micron</a><img src=\"https://static.tigerbbs.com/d789740a0d55698fce2eaa27ff334fcb\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Charles Knowles / Shutterstock.com<a href=\"https://laohu8.com/S/MU\">Micron</a> is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.<a href=\"https://laohu8.com/S/AA\">Alcoa</a><img src=\"https://static.tigerbbs.com/345c732c89a6bd214adff72fe56d3249\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Daniel J. Macy / Shutterstock.com<a href=\"https://laohu8.com/S/AA\">Alcoa</a> produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.<a href=\"https://laohu8.com/S/NTR\">Nutrien</a><img src=\"https://static.tigerbbs.com/cf261f41b67b978b2bccc50b86f9619b\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like <a href=\"https://laohu8.com/S/NTR\">Nutrien</a>, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.<a href=\"https://laohu8.com/S/AIG\">American International Group</a><img src=\"https://static.tigerbbs.com/4fbf6ee441b7aaaccd4fbe0cf78bfd2a\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.<a href=\"https://laohu8.com/S/MMM\">3M</a><img src=\"https://static.tigerbbs.com/dcfdc62e0b1977b35e871a578f6f8388\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: r.classen / Shutterstock.com<a href=\"https://laohu8.com/S/MMM\">3M</a> produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.<a href=\"https://laohu8.com/S/MSFT\">Microsoft</a><img src=\"https://static.tigerbbs.com/998767af9244c24d2eca1a6c74ee6b60\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: The Art of Pics / Shutterstock.comWhen 2022 began, <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.<a href=\"https://laohu8.com/S/PFE\">Pfizer</a><img src=\"https://static.tigerbbs.com/24582c18e5505b72fa27f4466b6dc4db\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: photobyphm / Shutterstock.com<a href=\"https://laohu8.com/S/PFE\">Pfizer</a> received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Undervalued Blue-Chip Stocks to Buy for June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Undervalued Blue-Chip Stocks to Buy for June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-27 13:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nThese undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities ...\n\n<a href=\"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NTR":"Nutrien Ltd.","MSFT":"微软","MMM":"3M","AIG":"美国国际集团","MU":"美光科技","AA":"美国铝业"},"source_url":"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154795776","content_text":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities giant.Nutrien: The undervalued Canadian firm is vital to food production.American International Group: AIG’s upside is attractive and its staid dividend smooths current volatility.3M: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.Microsoft: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.Pfizer: Vaccine sales will fuel future growth, making Pfizer noteworthy.With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.MicronSource: Charles Knowles / Shutterstock.comMicron is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.AlcoaSource: Daniel J. Macy / Shutterstock.comAlcoa produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.NutrienSource: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like Nutrien, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.American International GroupSource: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.3MSource: r.classen / Shutterstock.com3M produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.MicrosoftSource: The Art of Pics / Shutterstock.comWhen 2022 began, Microsoft stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.PfizerSource: photobyphm / Shutterstock.comPfizer received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9025114216,"gmtCreate":1653637502835,"gmtModify":1676535319165,"author":{"id":"3578016956086861","authorId":"3578016956086861","name":"JeremyEe","avatar":"https://static.tigerbbs.com/e4251e60b7916b8816ebb7a4c9bd615c","vip":1,"crmLevel":5,"crmLevelSwitch":1,"idStr":"3578016956086861","authorIdStr":"3578016956086861"},"htmlText":"9i","listText":"9i","text":"9i","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9025114216","repostId":1154795776,"repostType":4,"repost":{"id":"1154795776","pubTimestamp":1653628057,"share":"https://ttm.financial/m/news/1154795776?lang=&edition=fundamental","pubTime":"2022-05-27 13:07","market":"us","language":"en","title":"7 Undervalued Blue-Chip Stocks to Buy for June","url":"https://stock-news.laohu8.com/highlight/detail?id=1154795776","media":"InvestorPlace","summary":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock","content":"<html><head></head><body>These undervalued blue-chip stocks possess excellent long-term potential.<ul><li><a href=\"https://laohu8.com/S/MU\">Micron</a>: Semiconductor stock that blends growth and low valuation.</li><li><a href=\"https://laohu8.com/S/AA\">Alcoa</a>: Net income growth bodes very well for the commodities giant.</li><li><a href=\"https://laohu8.com/S/NTR\">Nutrien</a>: The undervalued Canadian firm is vital to food production.</li><li><a href=\"https://laohu8.com/S/AIG\">American International Group</a>: AIG’s upside is attractive and its staid dividend smooths current volatility.</li><li><a href=\"https://laohu8.com/S/MMM\">3M</a>: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.</li><li><a href=\"https://laohu8.com/S/MSFT\">Microsoft</a>: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.</li><li><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>: Vaccine sales will fuel future growth, making Pfizer noteworthy.</li></ul>With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.<a href=\"https://laohu8.com/S/MU\">Micron</a><img src=\"https://static.tigerbbs.com/d789740a0d55698fce2eaa27ff334fcb\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Charles Knowles / Shutterstock.com<a href=\"https://laohu8.com/S/MU\">Micron</a> is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.<a href=\"https://laohu8.com/S/AA\">Alcoa</a><img src=\"https://static.tigerbbs.com/345c732c89a6bd214adff72fe56d3249\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Daniel J. Macy / Shutterstock.com<a href=\"https://laohu8.com/S/AA\">Alcoa</a> produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.<a href=\"https://laohu8.com/S/NTR\">Nutrien</a><img src=\"https://static.tigerbbs.com/cf261f41b67b978b2bccc50b86f9619b\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like <a href=\"https://laohu8.com/S/NTR\">Nutrien</a>, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.<a href=\"https://laohu8.com/S/AIG\">American International Group</a><img src=\"https://static.tigerbbs.com/4fbf6ee441b7aaaccd4fbe0cf78bfd2a\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.<a href=\"https://laohu8.com/S/MMM\">3M</a><img src=\"https://static.tigerbbs.com/dcfdc62e0b1977b35e871a578f6f8388\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: r.classen / Shutterstock.com<a href=\"https://laohu8.com/S/MMM\">3M</a> produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.<a href=\"https://laohu8.com/S/MSFT\">Microsoft</a><img src=\"https://static.tigerbbs.com/998767af9244c24d2eca1a6c74ee6b60\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: The Art of Pics / Shutterstock.comWhen 2022 began, <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.<a href=\"https://laohu8.com/S/PFE\">Pfizer</a><img src=\"https://static.tigerbbs.com/24582c18e5505b72fa27f4466b6dc4db\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: photobyphm / Shutterstock.com<a href=\"https://laohu8.com/S/PFE\">Pfizer</a> received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Undervalued Blue-Chip Stocks to Buy for June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Undervalued Blue-Chip Stocks to Buy for June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-27 13:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nThese undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities ...\n\n<a href=\"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NTR":"Nutrien Ltd.","MSFT":"微软","MMM":"3M","AIG":"美国国际集团","MU":"美光科技","AA":"美国铝业"},"source_url":"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154795776","content_text":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities giant.Nutrien: The undervalued Canadian firm is vital to food production.American International Group: AIG’s upside is attractive and its staid dividend smooths current volatility.3M: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.Microsoft: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.Pfizer: Vaccine sales will fuel future growth, making Pfizer noteworthy.With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.MicronSource: Charles Knowles / Shutterstock.comMicron is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.AlcoaSource: Daniel J. Macy / Shutterstock.comAlcoa produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.NutrienSource: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like Nutrien, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.American International GroupSource: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.3MSource: r.classen / Shutterstock.com3M produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.MicrosoftSource: The Art of Pics / Shutterstock.comWhen 2022 began, Microsoft stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.PfizerSource: photobyphm / Shutterstock.comPfizer received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9025114610,"gmtCreate":1653637493530,"gmtModify":1676535319165,"author":{"id":"3578016956086861","authorId":"3578016956086861","name":"JeremyEe","avatar":"https://static.tigerbbs.com/e4251e60b7916b8816ebb7a4c9bd615c","vip":1,"crmLevel":5,"crmLevelSwitch":1,"idStr":"3578016956086861","authorIdStr":"3578016956086861"},"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9025114610","repostId":1154795776,"repostType":4,"repost":{"id":"1154795776","pubTimestamp":1653628057,"share":"https://ttm.financial/m/news/1154795776?lang=&edition=fundamental","pubTime":"2022-05-27 13:07","market":"us","language":"en","title":"7 Undervalued Blue-Chip Stocks to Buy for June","url":"https://stock-news.laohu8.com/highlight/detail?id=1154795776","media":"InvestorPlace","summary":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock","content":"<html><head></head><body>These undervalued blue-chip stocks possess excellent long-term potential.<ul><li><a href=\"https://laohu8.com/S/MU\">Micron</a>: Semiconductor stock that blends growth and low valuation.</li><li><a href=\"https://laohu8.com/S/AA\">Alcoa</a>: Net income growth bodes very well for the commodities giant.</li><li><a href=\"https://laohu8.com/S/NTR\">Nutrien</a>: The undervalued Canadian firm is vital to food production.</li><li><a href=\"https://laohu8.com/S/AIG\">American International Group</a>: AIG’s upside is attractive and its staid dividend smooths current volatility.</li><li><a href=\"https://laohu8.com/S/MMM\">3M</a>: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.</li><li><a href=\"https://laohu8.com/S/MSFT\">Microsoft</a>: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.</li><li><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>: Vaccine sales will fuel future growth, making Pfizer noteworthy.</li></ul>With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.<a href=\"https://laohu8.com/S/MU\">Micron</a><img src=\"https://static.tigerbbs.com/d789740a0d55698fce2eaa27ff334fcb\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Charles Knowles / Shutterstock.com<a href=\"https://laohu8.com/S/MU\">Micron</a> is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.<a href=\"https://laohu8.com/S/AA\">Alcoa</a><img src=\"https://static.tigerbbs.com/345c732c89a6bd214adff72fe56d3249\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Daniel J. Macy / Shutterstock.com<a href=\"https://laohu8.com/S/AA\">Alcoa</a> produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.<a href=\"https://laohu8.com/S/NTR\">Nutrien</a><img src=\"https://static.tigerbbs.com/cf261f41b67b978b2bccc50b86f9619b\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like <a href=\"https://laohu8.com/S/NTR\">Nutrien</a>, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.<a href=\"https://laohu8.com/S/AIG\">American International Group</a><img src=\"https://static.tigerbbs.com/4fbf6ee441b7aaaccd4fbe0cf78bfd2a\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.<a href=\"https://laohu8.com/S/MMM\">3M</a><img src=\"https://static.tigerbbs.com/dcfdc62e0b1977b35e871a578f6f8388\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: r.classen / Shutterstock.com<a href=\"https://laohu8.com/S/MMM\">3M</a> produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.<a href=\"https://laohu8.com/S/MSFT\">Microsoft</a><img src=\"https://static.tigerbbs.com/998767af9244c24d2eca1a6c74ee6b60\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: The Art of Pics / Shutterstock.comWhen 2022 began, <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.<a href=\"https://laohu8.com/S/PFE\">Pfizer</a><img src=\"https://static.tigerbbs.com/24582c18e5505b72fa27f4466b6dc4db\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: photobyphm / Shutterstock.com<a href=\"https://laohu8.com/S/PFE\">Pfizer</a> received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Undervalued Blue-Chip Stocks to Buy for June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Undervalued Blue-Chip Stocks to Buy for June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-27 13:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nThese undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities ...\n\n<a href=\"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NTR":"Nutrien Ltd.","MSFT":"微软","MMM":"3M","AIG":"美国国际集团","MU":"美光科技","AA":"美国铝业"},"source_url":"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154795776","content_text":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities giant.Nutrien: The undervalued Canadian firm is vital to food production.American International Group: AIG’s upside is attractive and its staid dividend smooths current volatility.3M: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.Microsoft: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.Pfizer: Vaccine sales will fuel future growth, making Pfizer noteworthy.With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.MicronSource: Charles Knowles / Shutterstock.comMicron is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.AlcoaSource: Daniel J. Macy / Shutterstock.comAlcoa produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.NutrienSource: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like Nutrien, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.American International GroupSource: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.3MSource: r.classen / Shutterstock.com3M produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.MicrosoftSource: The Art of Pics / Shutterstock.comWhen 2022 began, Microsoft stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.PfizerSource: photobyphm / Shutterstock.comPfizer received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9025112783,"gmtCreate":1653637290142,"gmtModify":1676535319118,"author":{"id":"4101950692484850","authorId":"4101950692484850","name":"AndyChoo","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"4101950692484850","authorIdStr":"4101950692484850"},"htmlText":"Micron is my top pick","listText":"Micron is my top pick","text":"Micron is my top pick","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9025112783","repostId":1154795776,"repostType":4,"repost":{"id":"1154795776","pubTimestamp":1653628057,"share":"https://ttm.financial/m/news/1154795776?lang=&edition=fundamental","pubTime":"2022-05-27 13:07","market":"us","language":"en","title":"7 Undervalued Blue-Chip Stocks to Buy for June","url":"https://stock-news.laohu8.com/highlight/detail?id=1154795776","media":"InvestorPlace","summary":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock","content":"<html><head></head><body>These undervalued blue-chip stocks possess excellent long-term potential.<ul><li><a href=\"https://laohu8.com/S/MU\">Micron</a>: Semiconductor stock that blends growth and low valuation.</li><li><a href=\"https://laohu8.com/S/AA\">Alcoa</a>: Net income growth bodes very well for the commodities giant.</li><li><a href=\"https://laohu8.com/S/NTR\">Nutrien</a>: The undervalued Canadian firm is vital to food production.</li><li><a href=\"https://laohu8.com/S/AIG\">American International Group</a>: AIG’s upside is attractive and its staid dividend smooths current volatility.</li><li><a href=\"https://laohu8.com/S/MMM\">3M</a>: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.</li><li><a href=\"https://laohu8.com/S/MSFT\">Microsoft</a>: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.</li><li><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>: Vaccine sales will fuel future growth, making Pfizer noteworthy.</li></ul>With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.<a href=\"https://laohu8.com/S/MU\">Micron</a><img src=\"https://static.tigerbbs.com/d789740a0d55698fce2eaa27ff334fcb\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Charles Knowles / Shutterstock.com<a href=\"https://laohu8.com/S/MU\">Micron</a> is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.<a href=\"https://laohu8.com/S/AA\">Alcoa</a><img src=\"https://static.tigerbbs.com/345c732c89a6bd214adff72fe56d3249\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Daniel J. Macy / Shutterstock.com<a href=\"https://laohu8.com/S/AA\">Alcoa</a> produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.<a href=\"https://laohu8.com/S/NTR\">Nutrien</a><img src=\"https://static.tigerbbs.com/cf261f41b67b978b2bccc50b86f9619b\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like <a href=\"https://laohu8.com/S/NTR\">Nutrien</a>, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.<a href=\"https://laohu8.com/S/AIG\">American International Group</a><img src=\"https://static.tigerbbs.com/4fbf6ee441b7aaaccd4fbe0cf78bfd2a\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.<a href=\"https://laohu8.com/S/MMM\">3M</a><img src=\"https://static.tigerbbs.com/dcfdc62e0b1977b35e871a578f6f8388\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: r.classen / Shutterstock.com<a href=\"https://laohu8.com/S/MMM\">3M</a> produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.<a href=\"https://laohu8.com/S/MSFT\">Microsoft</a><img src=\"https://static.tigerbbs.com/998767af9244c24d2eca1a6c74ee6b60\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: The Art of Pics / Shutterstock.comWhen 2022 began, <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.<a href=\"https://laohu8.com/S/PFE\">Pfizer</a><img src=\"https://static.tigerbbs.com/24582c18e5505b72fa27f4466b6dc4db\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: photobyphm / Shutterstock.com<a href=\"https://laohu8.com/S/PFE\">Pfizer</a> received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Undervalued Blue-Chip Stocks to Buy for June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Undervalued Blue-Chip Stocks to Buy for June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-27 13:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nThese undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities ...\n\n<a href=\"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NTR":"Nutrien Ltd.","MSFT":"微软","MMM":"3M","AIG":"美国国际集团","MU":"美光科技","AA":"美国铝业"},"source_url":"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154795776","content_text":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities giant.Nutrien: The undervalued Canadian firm is vital to food production.American International Group: AIG’s upside is attractive and its staid dividend smooths current volatility.3M: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.Microsoft: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.Pfizer: Vaccine sales will fuel future growth, making Pfizer noteworthy.With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.MicronSource: Charles Knowles / Shutterstock.comMicron is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.AlcoaSource: Daniel J. Macy / Shutterstock.comAlcoa produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.NutrienSource: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like Nutrien, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.American International GroupSource: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.3MSource: r.classen / Shutterstock.com3M produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.MicrosoftSource: The Art of Pics / Shutterstock.comWhen 2022 began, Microsoft stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.PfizerSource: photobyphm / Shutterstock.comPfizer received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9025112257,"gmtCreate":1653637249379,"gmtModify":1676535319111,"author":{"id":"3575367895713518","authorId":"3575367895713518","name":"Moneyong","avatar":"https://static.tigerbbs.com/310106f7833de54751b1a4f33ac43e61","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3575367895713518","authorIdStr":"3575367895713518"},"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9025112257","repostId":1154795776,"repostType":4,"repost":{"id":"1154795776","pubTimestamp":1653628057,"share":"https://ttm.financial/m/news/1154795776?lang=&edition=fundamental","pubTime":"2022-05-27 13:07","market":"us","language":"en","title":"7 Undervalued Blue-Chip Stocks to Buy for June","url":"https://stock-news.laohu8.com/highlight/detail?id=1154795776","media":"InvestorPlace","summary":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock","content":"<html><head></head><body>These undervalued blue-chip stocks possess excellent long-term potential.<ul><li><a href=\"https://laohu8.com/S/MU\">Micron</a>: Semiconductor stock that blends growth and low valuation.</li><li><a href=\"https://laohu8.com/S/AA\">Alcoa</a>: Net income growth bodes very well for the commodities giant.</li><li><a href=\"https://laohu8.com/S/NTR\">Nutrien</a>: The undervalued Canadian firm is vital to food production.</li><li><a href=\"https://laohu8.com/S/AIG\">American International Group</a>: AIG’s upside is attractive and its staid dividend smooths current volatility.</li><li><a href=\"https://laohu8.com/S/MMM\">3M</a>: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.</li><li><a href=\"https://laohu8.com/S/MSFT\">Microsoft</a>: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.</li><li><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>: Vaccine sales will fuel future growth, making Pfizer noteworthy.</li></ul>With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.<a href=\"https://laohu8.com/S/MU\">Micron</a><img src=\"https://static.tigerbbs.com/d789740a0d55698fce2eaa27ff334fcb\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Charles Knowles / Shutterstock.com<a href=\"https://laohu8.com/S/MU\">Micron</a> is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.<a href=\"https://laohu8.com/S/AA\">Alcoa</a><img src=\"https://static.tigerbbs.com/345c732c89a6bd214adff72fe56d3249\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Daniel J. Macy / Shutterstock.com<a href=\"https://laohu8.com/S/AA\">Alcoa</a> produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.<a href=\"https://laohu8.com/S/NTR\">Nutrien</a><img src=\"https://static.tigerbbs.com/cf261f41b67b978b2bccc50b86f9619b\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like <a href=\"https://laohu8.com/S/NTR\">Nutrien</a>, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.<a href=\"https://laohu8.com/S/AIG\">American International Group</a><img src=\"https://static.tigerbbs.com/4fbf6ee441b7aaaccd4fbe0cf78bfd2a\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.<a href=\"https://laohu8.com/S/MMM\">3M</a><img src=\"https://static.tigerbbs.com/dcfdc62e0b1977b35e871a578f6f8388\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: r.classen / Shutterstock.com<a href=\"https://laohu8.com/S/MMM\">3M</a> produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.<a href=\"https://laohu8.com/S/MSFT\">Microsoft</a><img src=\"https://static.tigerbbs.com/998767af9244c24d2eca1a6c74ee6b60\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: The Art of Pics / Shutterstock.comWhen 2022 began, <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.<a href=\"https://laohu8.com/S/PFE\">Pfizer</a><img src=\"https://static.tigerbbs.com/24582c18e5505b72fa27f4466b6dc4db\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: photobyphm / Shutterstock.com<a href=\"https://laohu8.com/S/PFE\">Pfizer</a> received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Undervalued Blue-Chip Stocks to Buy for June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Undervalued Blue-Chip Stocks to Buy for June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-27 13:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nThese undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities ...\n\n<a href=\"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NTR":"Nutrien Ltd.","MSFT":"微软","MMM":"3M","AIG":"美国国际集团","MU":"美光科技","AA":"美国铝业"},"source_url":"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154795776","content_text":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities giant.Nutrien: The undervalued Canadian firm is vital to food production.American International Group: AIG’s upside is attractive and its staid dividend smooths current volatility.3M: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.Microsoft: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.Pfizer: Vaccine sales will fuel future growth, making Pfizer noteworthy.With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.MicronSource: Charles Knowles / Shutterstock.comMicron is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.AlcoaSource: Daniel J. Macy / Shutterstock.comAlcoa produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.NutrienSource: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like Nutrien, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.American International GroupSource: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.3MSource: r.classen / Shutterstock.com3M produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.MicrosoftSource: The Art of Pics / Shutterstock.comWhen 2022 began, Microsoft stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.PfizerSource: photobyphm / Shutterstock.comPfizer received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9025112376,"gmtCreate":1653637150495,"gmtModify":1676535319103,"author":{"id":"3575673754947065","authorId":"3575673754947065","name":"Nana_seven","avatar":"https://static.tigerbbs.com/cbfa864cf0a3b766b4090b0ad3b67e69","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":5,"crmLevelSwitch":0,"idStr":"3575673754947065","authorIdStr":"3575673754947065"},"htmlText":"Pls like&nbsp;","listText":"Pls like&nbsp;","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9025112376","repostId":1154795776,"repostType":4,"repost":{"id":"1154795776","pubTimestamp":1653628057,"share":"https://ttm.financial/m/news/1154795776?lang=&edition=fundamental","pubTime":"2022-05-27 13:07","market":"us","language":"en","title":"7 Undervalued Blue-Chip Stocks to Buy for June","url":"https://stock-news.laohu8.com/highlight/detail?id=1154795776","media":"InvestorPlace","summary":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock","content":"<html><head></head><body>These undervalued blue-chip stocks possess excellent long-term potential.<ul><li><a href=\"https://laohu8.com/S/MU\">Micron</a>: Semiconductor stock that blends growth and low valuation.</li><li><a href=\"https://laohu8.com/S/AA\">Alcoa</a>: Net income growth bodes very well for the commodities giant.</li><li><a href=\"https://laohu8.com/S/NTR\">Nutrien</a>: The undervalued Canadian firm is vital to food production.</li><li><a href=\"https://laohu8.com/S/AIG\">American International Group</a>: AIG’s upside is attractive and its staid dividend smooths current volatility.</li><li><a href=\"https://laohu8.com/S/MMM\">3M</a>: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.</li><li><a href=\"https://laohu8.com/S/MSFT\">Microsoft</a>: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.</li><li><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>: Vaccine sales will fuel future growth, making Pfizer noteworthy.</li></ul>With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.<a href=\"https://laohu8.com/S/MU\">Micron</a><img src=\"https://static.tigerbbs.com/d789740a0d55698fce2eaa27ff334fcb\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Charles Knowles / Shutterstock.com<a href=\"https://laohu8.com/S/MU\">Micron</a> is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.<a href=\"https://laohu8.com/S/AA\">Alcoa</a><img src=\"https://static.tigerbbs.com/345c732c89a6bd214adff72fe56d3249\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Daniel J. Macy / Shutterstock.com<a href=\"https://laohu8.com/S/AA\">Alcoa</a> produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.<a href=\"https://laohu8.com/S/NTR\">Nutrien</a><img src=\"https://static.tigerbbs.com/cf261f41b67b978b2bccc50b86f9619b\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like <a href=\"https://laohu8.com/S/NTR\">Nutrien</a>, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.<a href=\"https://laohu8.com/S/AIG\">American International Group</a><img src=\"https://static.tigerbbs.com/4fbf6ee441b7aaaccd4fbe0cf78bfd2a\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.<a href=\"https://laohu8.com/S/MMM\">3M</a><img src=\"https://static.tigerbbs.com/dcfdc62e0b1977b35e871a578f6f8388\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: r.classen / Shutterstock.com<a href=\"https://laohu8.com/S/MMM\">3M</a> produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.<a href=\"https://laohu8.com/S/MSFT\">Microsoft</a><img src=\"https://static.tigerbbs.com/998767af9244c24d2eca1a6c74ee6b60\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: The Art of Pics / Shutterstock.comWhen 2022 began, <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.<a href=\"https://laohu8.com/S/PFE\">Pfizer</a><img src=\"https://static.tigerbbs.com/24582c18e5505b72fa27f4466b6dc4db\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: photobyphm / Shutterstock.com<a href=\"https://laohu8.com/S/PFE\">Pfizer</a> received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Undervalued Blue-Chip Stocks to Buy for June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Undervalued Blue-Chip Stocks to Buy for June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-27 13:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nThese undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities ...\n\n<a href=\"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NTR":"Nutrien Ltd.","MSFT":"微软","MMM":"3M","AIG":"美国国际集团","MU":"美光科技","AA":"美国铝业"},"source_url":"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154795776","content_text":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities giant.Nutrien: The undervalued Canadian firm is vital to food production.American International Group: AIG’s upside is attractive and its staid dividend smooths current volatility.3M: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.Microsoft: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.Pfizer: Vaccine sales will fuel future growth, making Pfizer noteworthy.With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.MicronSource: Charles Knowles / Shutterstock.comMicron is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.AlcoaSource: Daniel J. Macy / Shutterstock.comAlcoa produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.NutrienSource: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like Nutrien, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.American International GroupSource: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.3MSource: r.classen / Shutterstock.com3M produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.MicrosoftSource: The Art of Pics / Shutterstock.comWhen 2022 began, Microsoft stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.PfizerSource: photobyphm / Shutterstock.comPfizer received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9025118202,"gmtCreate":1653636819406,"gmtModify":1676535319072,"author":{"id":"3579827147050987","authorId":"3579827147050987","name":"xupper22","avatar":"https://static.tigerbbs.com/6b13c95cf147fc91a64e304d76553827","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":3,"crmLevelSwitch":1,"idStr":"3579827147050987","authorIdStr":"3579827147050987"},"htmlText":"Invest in Pfizer only because it's one of the biggest names in this space. If you are investing in Pfizer because of covid, your baseline mindset is wrong. Pfizer in covid is corruption, we still have no idea if they will be punished or not - extreme volatility. However, their other products and future corruption attempts may prove profitable once again.","listText":"Invest in Pfizer only because it's one of the biggest names in this space. If you are investing in Pfizer because of covid, your baseline mindset is wrong. Pfizer in covid is corruption, we still have no idea if they will be punished or not - extreme volatility. However, their other products and future corruption attempts may prove profitable once again.","text":"Invest in Pfizer only because it's one of the biggest names in this space. If you are investing in Pfizer because of covid, your baseline mindset is wrong. Pfizer in covid is corruption, we still have no idea if they will be punished or not - extreme volatility. However, their other products and future corruption attempts may prove profitable once again.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9025118202","repostId":1154795776,"repostType":2,"repost":{"id":"1154795776","pubTimestamp":1653628057,"share":"https://ttm.financial/m/news/1154795776?lang=&edition=fundamental","pubTime":"2022-05-27 13:07","market":"us","language":"en","title":"7 Undervalued Blue-Chip Stocks to Buy for June","url":"https://stock-news.laohu8.com/highlight/detail?id=1154795776","media":"InvestorPlace","summary":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock","content":"<html><head></head><body>These undervalued blue-chip stocks possess excellent long-term potential.<ul><li><a href=\"https://laohu8.com/S/MU\">Micron</a>: Semiconductor stock that blends growth and low valuation.</li><li><a href=\"https://laohu8.com/S/AA\">Alcoa</a>: Net income growth bodes very well for the commodities giant.</li><li><a href=\"https://laohu8.com/S/NTR\">Nutrien</a>: The undervalued Canadian firm is vital to food production.</li><li><a href=\"https://laohu8.com/S/AIG\">American International Group</a>: AIG’s upside is attractive and its staid dividend smooths current volatility.</li><li><a href=\"https://laohu8.com/S/MMM\">3M</a>: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.</li><li><a href=\"https://laohu8.com/S/MSFT\">Microsoft</a>: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.</li><li><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>: Vaccine sales will fuel future growth, making Pfizer noteworthy.</li></ul>With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.<a href=\"https://laohu8.com/S/MU\">Micron</a><img src=\"https://static.tigerbbs.com/d789740a0d55698fce2eaa27ff334fcb\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Charles Knowles / Shutterstock.com<a href=\"https://laohu8.com/S/MU\">Micron</a> is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.<a href=\"https://laohu8.com/S/AA\">Alcoa</a><img src=\"https://static.tigerbbs.com/345c732c89a6bd214adff72fe56d3249\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Daniel J. Macy / Shutterstock.com<a href=\"https://laohu8.com/S/AA\">Alcoa</a> produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.<a href=\"https://laohu8.com/S/NTR\">Nutrien</a><img src=\"https://static.tigerbbs.com/cf261f41b67b978b2bccc50b86f9619b\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like <a href=\"https://laohu8.com/S/NTR\">Nutrien</a>, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.<a href=\"https://laohu8.com/S/AIG\">American International Group</a><img src=\"https://static.tigerbbs.com/4fbf6ee441b7aaaccd4fbe0cf78bfd2a\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.<a href=\"https://laohu8.com/S/MMM\">3M</a><img src=\"https://static.tigerbbs.com/dcfdc62e0b1977b35e871a578f6f8388\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: r.classen / Shutterstock.com<a href=\"https://laohu8.com/S/MMM\">3M</a> produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.<a href=\"https://laohu8.com/S/MSFT\">Microsoft</a><img src=\"https://static.tigerbbs.com/998767af9244c24d2eca1a6c74ee6b60\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: The Art of Pics / Shutterstock.comWhen 2022 began, <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.<a href=\"https://laohu8.com/S/PFE\">Pfizer</a><img src=\"https://static.tigerbbs.com/24582c18e5505b72fa27f4466b6dc4db\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: photobyphm / Shutterstock.com<a href=\"https://laohu8.com/S/PFE\">Pfizer</a> received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Undervalued Blue-Chip Stocks to Buy for June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Undervalued Blue-Chip Stocks to Buy for June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-27 13:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nThese undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities ...\n\n<a href=\"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NTR":"Nutrien Ltd.","MSFT":"微软","MMM":"3M","AIG":"美国国际集团","MU":"美光科技","AA":"美国铝业"},"source_url":"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154795776","content_text":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities giant.Nutrien: The undervalued Canadian firm is vital to food production.American International Group: AIG’s upside is attractive and its staid dividend smooths current volatility.3M: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.Microsoft: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.Pfizer: Vaccine sales will fuel future growth, making Pfizer noteworthy.With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.MicronSource: Charles Knowles / Shutterstock.comMicron is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.AlcoaSource: Daniel J. Macy / Shutterstock.comAlcoa produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.NutrienSource: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like Nutrien, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.American International GroupSource: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.3MSource: r.classen / Shutterstock.com3M produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.MicrosoftSource: The Art of Pics / Shutterstock.comWhen 2022 began, Microsoft stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.PfizerSource: photobyphm / Shutterstock.comPfizer received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9025111599,"gmtCreate":1653636577111,"gmtModify":1676535319056,"author":{"id":"3569568422679710","authorId":"3569568422679710","name":"xJAxAx","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3569568422679710","authorIdStr":"3569568422679710"},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9025111599","repostId":1154795776,"repostType":4,"repost":{"id":"1154795776","pubTimestamp":1653628057,"share":"https://ttm.financial/m/news/1154795776?lang=&edition=fundamental","pubTime":"2022-05-27 13:07","market":"us","language":"en","title":"7 Undervalued Blue-Chip Stocks to Buy for June","url":"https://stock-news.laohu8.com/highlight/detail?id=1154795776","media":"InvestorPlace","summary":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock","content":"<html><head></head><body>These undervalued blue-chip stocks possess excellent long-term potential.<ul><li><a href=\"https://laohu8.com/S/MU\">Micron</a>: Semiconductor stock that blends growth and low valuation.</li><li><a href=\"https://laohu8.com/S/AA\">Alcoa</a>: Net income growth bodes very well for the commodities giant.</li><li><a href=\"https://laohu8.com/S/NTR\">Nutrien</a>: The undervalued Canadian firm is vital to food production.</li><li><a href=\"https://laohu8.com/S/AIG\">American International Group</a>: AIG’s upside is attractive and its staid dividend smooths current volatility.</li><li><a href=\"https://laohu8.com/S/MMM\">3M</a>: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.</li><li><a href=\"https://laohu8.com/S/MSFT\">Microsoft</a>: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.</li><li><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>: Vaccine sales will fuel future growth, making Pfizer noteworthy.</li></ul>With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.<a href=\"https://laohu8.com/S/MU\">Micron</a><img src=\"https://static.tigerbbs.com/d789740a0d55698fce2eaa27ff334fcb\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Charles Knowles / Shutterstock.com<a href=\"https://laohu8.com/S/MU\">Micron</a> is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.<a href=\"https://laohu8.com/S/AA\">Alcoa</a><img src=\"https://static.tigerbbs.com/345c732c89a6bd214adff72fe56d3249\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Daniel J. Macy / Shutterstock.com<a href=\"https://laohu8.com/S/AA\">Alcoa</a> produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.<a href=\"https://laohu8.com/S/NTR\">Nutrien</a><img src=\"https://static.tigerbbs.com/cf261f41b67b978b2bccc50b86f9619b\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like <a href=\"https://laohu8.com/S/NTR\">Nutrien</a>, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.<a href=\"https://laohu8.com/S/AIG\">American International Group</a><img src=\"https://static.tigerbbs.com/4fbf6ee441b7aaaccd4fbe0cf78bfd2a\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.<a href=\"https://laohu8.com/S/MMM\">3M</a><img src=\"https://static.tigerbbs.com/dcfdc62e0b1977b35e871a578f6f8388\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: r.classen / Shutterstock.com<a href=\"https://laohu8.com/S/MMM\">3M</a> produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.<a href=\"https://laohu8.com/S/MSFT\">Microsoft</a><img src=\"https://static.tigerbbs.com/998767af9244c24d2eca1a6c74ee6b60\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: The Art of Pics / Shutterstock.comWhen 2022 began, <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.<a href=\"https://laohu8.com/S/PFE\">Pfizer</a><img src=\"https://static.tigerbbs.com/24582c18e5505b72fa27f4466b6dc4db\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: photobyphm / Shutterstock.com<a href=\"https://laohu8.com/S/PFE\">Pfizer</a> received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Undervalued Blue-Chip Stocks to Buy for June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Undervalued Blue-Chip Stocks to Buy for June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-27 13:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nThese undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities ...\n\n<a href=\"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NTR":"Nutrien Ltd.","MSFT":"微软","MMM":"3M","AIG":"美国国际集团","MU":"美光科技","AA":"美国铝业"},"source_url":"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154795776","content_text":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities giant.Nutrien: The undervalued Canadian firm is vital to food production.American International Group: AIG’s upside is attractive and its staid dividend smooths current volatility.3M: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.Microsoft: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.Pfizer: Vaccine sales will fuel future growth, making Pfizer noteworthy.With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.MicronSource: Charles Knowles / Shutterstock.comMicron is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.AlcoaSource: Daniel J. Macy / Shutterstock.comAlcoa produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.NutrienSource: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like Nutrien, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.American International GroupSource: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.3MSource: r.classen / Shutterstock.com3M produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.MicrosoftSource: The Art of Pics / Shutterstock.comWhen 2022 began, Microsoft stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.PfizerSource: photobyphm / Shutterstock.comPfizer received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9025113756,"gmtCreate":1653636432775,"gmtModify":1676535319026,"author":{"id":"4110126448550012","authorId":"4110126448550012","name":"Payneri","avatar":"https://community-static.tradeup.com/news/f523c00ecd00b27a2a30216bac7505e7","vip":1,"crmLevel":2,"crmLevelSwitch":1,"idStr":"4110126448550012","authorIdStr":"4110126448550012"},"htmlText":"Interesting view","listText":"Interesting view","text":"Interesting view","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9025113756","repostId":1154795776,"repostType":4,"repost":{"id":"1154795776","pubTimestamp":1653628057,"share":"https://ttm.financial/m/news/1154795776?lang=&edition=fundamental","pubTime":"2022-05-27 13:07","market":"us","language":"en","title":"7 Undervalued Blue-Chip Stocks to Buy for June","url":"https://stock-news.laohu8.com/highlight/detail?id=1154795776","media":"InvestorPlace","summary":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock","content":"<html><head></head><body>These undervalued blue-chip stocks possess excellent long-term potential.<ul><li><a href=\"https://laohu8.com/S/MU\">Micron</a>: Semiconductor stock that blends growth and low valuation.</li><li><a href=\"https://laohu8.com/S/AA\">Alcoa</a>: Net income growth bodes very well for the commodities giant.</li><li><a href=\"https://laohu8.com/S/NTR\">Nutrien</a>: The undervalued Canadian firm is vital to food production.</li><li><a href=\"https://laohu8.com/S/AIG\">American International Group</a>: AIG’s upside is attractive and its staid dividend smooths current volatility.</li><li><a href=\"https://laohu8.com/S/MMM\">3M</a>: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.</li><li><a href=\"https://laohu8.com/S/MSFT\">Microsoft</a>: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.</li><li><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>: Vaccine sales will fuel future growth, making Pfizer noteworthy.</li></ul>With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.<a href=\"https://laohu8.com/S/MU\">Micron</a><img src=\"https://static.tigerbbs.com/d789740a0d55698fce2eaa27ff334fcb\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Charles Knowles / Shutterstock.com<a href=\"https://laohu8.com/S/MU\">Micron</a> is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.<a href=\"https://laohu8.com/S/AA\">Alcoa</a><img src=\"https://static.tigerbbs.com/345c732c89a6bd214adff72fe56d3249\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Daniel J. Macy / Shutterstock.com<a href=\"https://laohu8.com/S/AA\">Alcoa</a> produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.<a href=\"https://laohu8.com/S/NTR\">Nutrien</a><img src=\"https://static.tigerbbs.com/cf261f41b67b978b2bccc50b86f9619b\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like <a href=\"https://laohu8.com/S/NTR\">Nutrien</a>, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.<a href=\"https://laohu8.com/S/AIG\">American International Group</a><img src=\"https://static.tigerbbs.com/4fbf6ee441b7aaaccd4fbe0cf78bfd2a\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.<a href=\"https://laohu8.com/S/MMM\">3M</a><img src=\"https://static.tigerbbs.com/dcfdc62e0b1977b35e871a578f6f8388\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: r.classen / Shutterstock.com<a href=\"https://laohu8.com/S/MMM\">3M</a> produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.<a href=\"https://laohu8.com/S/MSFT\">Microsoft</a><img src=\"https://static.tigerbbs.com/998767af9244c24d2eca1a6c74ee6b60\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: The Art of Pics / Shutterstock.comWhen 2022 began, <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.<a href=\"https://laohu8.com/S/PFE\">Pfizer</a><img src=\"https://static.tigerbbs.com/24582c18e5505b72fa27f4466b6dc4db\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: photobyphm / Shutterstock.com<a href=\"https://laohu8.com/S/PFE\">Pfizer</a> received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Undervalued Blue-Chip Stocks to Buy for June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Undervalued Blue-Chip Stocks to Buy for June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-27 13:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nThese undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities ...\n\n<a href=\"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NTR":"Nutrien Ltd.","MSFT":"微软","MMM":"3M","AIG":"美国国际集团","MU":"美光科技","AA":"美国铝业"},"source_url":"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154795776","content_text":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities giant.Nutrien: The undervalued Canadian firm is vital to food production.American International Group: AIG’s upside is attractive and its staid dividend smooths current volatility.3M: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.Microsoft: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.Pfizer: Vaccine sales will fuel future growth, making Pfizer noteworthy.With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.MicronSource: Charles Knowles / Shutterstock.comMicron is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.AlcoaSource: Daniel J. Macy / Shutterstock.comAlcoa produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.NutrienSource: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like Nutrien, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.American International GroupSource: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.3MSource: r.classen / Shutterstock.com3M produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.MicrosoftSource: The Art of Pics / Shutterstock.comWhen 2022 began, Microsoft stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.PfizerSource: photobyphm / Shutterstock.comPfizer received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9025137295,"gmtCreate":1653635841317,"gmtModify":1676535318942,"author":{"id":"4100325483048030","authorId":"4100325483048030","name":"Chris Tan","avatar":"https://community-static.tradeup.com/news/234d0c8219838a66f0165bcb29277534","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4100325483048030","authorIdStr":"4100325483048030"},"htmlText":"🏃‍♂️🏃‍♂️🏃‍♂️","listText":"🏃‍♂️🏃‍♂️🏃‍♂️","text":"🏃‍♂️🏃‍♂️🏃‍♂️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9025137295","repostId":1154795776,"repostType":4,"repost":{"id":"1154795776","pubTimestamp":1653628057,"share":"https://ttm.financial/m/news/1154795776?lang=&edition=fundamental","pubTime":"2022-05-27 13:07","market":"us","language":"en","title":"7 Undervalued Blue-Chip Stocks to Buy for June","url":"https://stock-news.laohu8.com/highlight/detail?id=1154795776","media":"InvestorPlace","summary":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock","content":"<html><head></head><body>These undervalued blue-chip stocks possess excellent long-term potential.<ul><li><a href=\"https://laohu8.com/S/MU\">Micron</a>: Semiconductor stock that blends growth and low valuation.</li><li><a href=\"https://laohu8.com/S/AA\">Alcoa</a>: Net income growth bodes very well for the commodities giant.</li><li><a href=\"https://laohu8.com/S/NTR\">Nutrien</a>: The undervalued Canadian firm is vital to food production.</li><li><a href=\"https://laohu8.com/S/AIG\">American International Group</a>: AIG’s upside is attractive and its staid dividend smooths current volatility.</li><li><a href=\"https://laohu8.com/S/MMM\">3M</a>: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.</li><li><a href=\"https://laohu8.com/S/MSFT\">Microsoft</a>: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.</li><li><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>: Vaccine sales will fuel future growth, making Pfizer noteworthy.</li></ul>With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.<a href=\"https://laohu8.com/S/MU\">Micron</a><img src=\"https://static.tigerbbs.com/d789740a0d55698fce2eaa27ff334fcb\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Charles Knowles / Shutterstock.com<a href=\"https://laohu8.com/S/MU\">Micron</a> is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.<a href=\"https://laohu8.com/S/AA\">Alcoa</a><img src=\"https://static.tigerbbs.com/345c732c89a6bd214adff72fe56d3249\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Daniel J. Macy / Shutterstock.com<a href=\"https://laohu8.com/S/AA\">Alcoa</a> produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.<a href=\"https://laohu8.com/S/NTR\">Nutrien</a><img src=\"https://static.tigerbbs.com/cf261f41b67b978b2bccc50b86f9619b\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like <a href=\"https://laohu8.com/S/NTR\">Nutrien</a>, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.<a href=\"https://laohu8.com/S/AIG\">American International Group</a><img src=\"https://static.tigerbbs.com/4fbf6ee441b7aaaccd4fbe0cf78bfd2a\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.<a href=\"https://laohu8.com/S/MMM\">3M</a><img src=\"https://static.tigerbbs.com/dcfdc62e0b1977b35e871a578f6f8388\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: r.classen / Shutterstock.com<a href=\"https://laohu8.com/S/MMM\">3M</a> produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.<a href=\"https://laohu8.com/S/MSFT\">Microsoft</a><img src=\"https://static.tigerbbs.com/998767af9244c24d2eca1a6c74ee6b60\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: The Art of Pics / Shutterstock.comWhen 2022 began, <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.<a href=\"https://laohu8.com/S/PFE\">Pfizer</a><img src=\"https://static.tigerbbs.com/24582c18e5505b72fa27f4466b6dc4db\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: photobyphm / Shutterstock.com<a href=\"https://laohu8.com/S/PFE\">Pfizer</a> received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Undervalued Blue-Chip Stocks to Buy for June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Undervalued Blue-Chip Stocks to Buy for June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-27 13:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nThese undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities ...\n\n<a href=\"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NTR":"Nutrien Ltd.","MSFT":"微软","MMM":"3M","AIG":"美国国际集团","MU":"美光科技","AA":"美国铝业"},"source_url":"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154795776","content_text":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities giant.Nutrien: The undervalued Canadian firm is vital to food production.American International Group: AIG’s upside is attractive and its staid dividend smooths current volatility.3M: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.Microsoft: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.Pfizer: Vaccine sales will fuel future growth, making Pfizer noteworthy.With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.MicronSource: Charles Knowles / Shutterstock.comMicron is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.AlcoaSource: Daniel J. Macy / Shutterstock.comAlcoa produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.NutrienSource: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like Nutrien, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.American International GroupSource: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.3MSource: r.classen / Shutterstock.com3M produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.MicrosoftSource: The Art of Pics / Shutterstock.comWhen 2022 began, Microsoft stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.PfizerSource: photobyphm / Shutterstock.comPfizer received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9025137125,"gmtCreate":1653635784567,"gmtModify":1676535318935,"author":{"id":"4098528367477030","authorId":"4098528367477030","name":"Verine","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","crmLevel":3,"crmLevelSwitch":0,"idStr":"4098528367477030","authorIdStr":"4098528367477030"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9025137125","repostId":1154795776,"repostType":4,"repost":{"id":"1154795776","pubTimestamp":1653628057,"share":"https://ttm.financial/m/news/1154795776?lang=&edition=fundamental","pubTime":"2022-05-27 13:07","market":"us","language":"en","title":"7 Undervalued Blue-Chip Stocks to Buy for June","url":"https://stock-news.laohu8.com/highlight/detail?id=1154795776","media":"InvestorPlace","summary":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock","content":"<html><head></head><body>These undervalued blue-chip stocks possess excellent long-term potential.<ul><li><a href=\"https://laohu8.com/S/MU\">Micron</a>: Semiconductor stock that blends growth and low valuation.</li><li><a href=\"https://laohu8.com/S/AA\">Alcoa</a>: Net income growth bodes very well for the commodities giant.</li><li><a href=\"https://laohu8.com/S/NTR\">Nutrien</a>: The undervalued Canadian firm is vital to food production.</li><li><a href=\"https://laohu8.com/S/AIG\">American International Group</a>: AIG’s upside is attractive and its staid dividend smooths current volatility.</li><li><a href=\"https://laohu8.com/S/MMM\">3M</a>: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.</li><li><a href=\"https://laohu8.com/S/MSFT\">Microsoft</a>: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.</li><li><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>: Vaccine sales will fuel future growth, making Pfizer noteworthy.</li></ul>With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.<a href=\"https://laohu8.com/S/MU\">Micron</a><img src=\"https://static.tigerbbs.com/d789740a0d55698fce2eaa27ff334fcb\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Charles Knowles / Shutterstock.com<a href=\"https://laohu8.com/S/MU\">Micron</a> is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.<a href=\"https://laohu8.com/S/AA\">Alcoa</a><img src=\"https://static.tigerbbs.com/345c732c89a6bd214adff72fe56d3249\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Daniel J. Macy / Shutterstock.com<a href=\"https://laohu8.com/S/AA\">Alcoa</a> produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.<a href=\"https://laohu8.com/S/NTR\">Nutrien</a><img src=\"https://static.tigerbbs.com/cf261f41b67b978b2bccc50b86f9619b\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like <a href=\"https://laohu8.com/S/NTR\">Nutrien</a>, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.<a href=\"https://laohu8.com/S/AIG\">American International Group</a><img src=\"https://static.tigerbbs.com/4fbf6ee441b7aaaccd4fbe0cf78bfd2a\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.<a href=\"https://laohu8.com/S/MMM\">3M</a><img src=\"https://static.tigerbbs.com/dcfdc62e0b1977b35e871a578f6f8388\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: r.classen / Shutterstock.com<a href=\"https://laohu8.com/S/MMM\">3M</a> produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.<a href=\"https://laohu8.com/S/MSFT\">Microsoft</a><img src=\"https://static.tigerbbs.com/998767af9244c24d2eca1a6c74ee6b60\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: The Art of Pics / Shutterstock.comWhen 2022 began, <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.<a href=\"https://laohu8.com/S/PFE\">Pfizer</a><img src=\"https://static.tigerbbs.com/24582c18e5505b72fa27f4466b6dc4db\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: photobyphm / Shutterstock.com<a href=\"https://laohu8.com/S/PFE\">Pfizer</a> received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Undervalued Blue-Chip Stocks to Buy for June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Undervalued Blue-Chip Stocks to Buy for June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-27 13:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nThese undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities ...\n\n<a href=\"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NTR":"Nutrien Ltd.","MSFT":"微软","MMM":"3M","AIG":"美国国际集团","MU":"美光科技","AA":"美国铝业"},"source_url":"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154795776","content_text":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities giant.Nutrien: The undervalued Canadian firm is vital to food production.American International Group: AIG’s upside is attractive and its staid dividend smooths current volatility.3M: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.Microsoft: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.Pfizer: Vaccine sales will fuel future growth, making Pfizer noteworthy.With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.MicronSource: Charles Knowles / Shutterstock.comMicron is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.AlcoaSource: Daniel J. Macy / Shutterstock.comAlcoa produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.NutrienSource: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like Nutrien, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.American International GroupSource: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.3MSource: r.classen / Shutterstock.com3M produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.MicrosoftSource: The Art of Pics / Shutterstock.comWhen 2022 began, Microsoft stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.PfizerSource: photobyphm / Shutterstock.comPfizer received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9025134687,"gmtCreate":1653635635949,"gmtModify":1676535318920,"author":{"id":"3555000456336821","authorId":"3555000456336821","name":"gamerxyj","avatar":"https://static.tigerbbs.com/8ca581741e24428089f21c4e11ff275c","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3555000456336821","authorIdStr":"3555000456336821"},"htmlText":"Can consider 👍","listText":"Can consider 👍","text":"Can consider 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9025134687","repostId":1154795776,"repostType":4,"repost":{"id":"1154795776","pubTimestamp":1653628057,"share":"https://ttm.financial/m/news/1154795776?lang=&edition=fundamental","pubTime":"2022-05-27 13:07","market":"us","language":"en","title":"7 Undervalued Blue-Chip Stocks to Buy for June","url":"https://stock-news.laohu8.com/highlight/detail?id=1154795776","media":"InvestorPlace","summary":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock","content":"<html><head></head><body>These undervalued blue-chip stocks possess excellent long-term potential.<ul><li><a href=\"https://laohu8.com/S/MU\">Micron</a>: Semiconductor stock that blends growth and low valuation.</li><li><a href=\"https://laohu8.com/S/AA\">Alcoa</a>: Net income growth bodes very well for the commodities giant.</li><li><a href=\"https://laohu8.com/S/NTR\">Nutrien</a>: The undervalued Canadian firm is vital to food production.</li><li><a href=\"https://laohu8.com/S/AIG\">American International Group</a>: AIG’s upside is attractive and its staid dividend smooths current volatility.</li><li><a href=\"https://laohu8.com/S/MMM\">3M</a>: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.</li><li><a href=\"https://laohu8.com/S/MSFT\">Microsoft</a>: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.</li><li><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>: Vaccine sales will fuel future growth, making Pfizer noteworthy.</li></ul>With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.<a href=\"https://laohu8.com/S/MU\">Micron</a><img src=\"https://static.tigerbbs.com/d789740a0d55698fce2eaa27ff334fcb\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Charles Knowles / Shutterstock.com<a href=\"https://laohu8.com/S/MU\">Micron</a> is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.<a href=\"https://laohu8.com/S/AA\">Alcoa</a><img src=\"https://static.tigerbbs.com/345c732c89a6bd214adff72fe56d3249\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Daniel J. Macy / Shutterstock.com<a href=\"https://laohu8.com/S/AA\">Alcoa</a> produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.<a href=\"https://laohu8.com/S/NTR\">Nutrien</a><img src=\"https://static.tigerbbs.com/cf261f41b67b978b2bccc50b86f9619b\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like <a href=\"https://laohu8.com/S/NTR\">Nutrien</a>, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.<a href=\"https://laohu8.com/S/AIG\">American International Group</a><img src=\"https://static.tigerbbs.com/4fbf6ee441b7aaaccd4fbe0cf78bfd2a\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.<a href=\"https://laohu8.com/S/MMM\">3M</a><img src=\"https://static.tigerbbs.com/dcfdc62e0b1977b35e871a578f6f8388\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: r.classen / Shutterstock.com<a href=\"https://laohu8.com/S/MMM\">3M</a> produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.<a href=\"https://laohu8.com/S/MSFT\">Microsoft</a><img src=\"https://static.tigerbbs.com/998767af9244c24d2eca1a6c74ee6b60\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: The Art of Pics / Shutterstock.comWhen 2022 began, <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.<a href=\"https://laohu8.com/S/PFE\">Pfizer</a><img src=\"https://static.tigerbbs.com/24582c18e5505b72fa27f4466b6dc4db\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: photobyphm / Shutterstock.com<a href=\"https://laohu8.com/S/PFE\">Pfizer</a> received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Undervalued Blue-Chip Stocks to Buy for June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Undervalued Blue-Chip Stocks to Buy for June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-27 13:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nThese undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities ...\n\n<a href=\"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NTR":"Nutrien Ltd.","MSFT":"微软","MMM":"3M","AIG":"美国国际集团","MU":"美光科技","AA":"美国铝业"},"source_url":"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154795776","content_text":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities giant.Nutrien: The undervalued Canadian firm is vital to food production.American International Group: AIG’s upside is attractive and its staid dividend smooths current volatility.3M: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.Microsoft: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.Pfizer: Vaccine sales will fuel future growth, making Pfizer noteworthy.With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.MicronSource: Charles Knowles / Shutterstock.comMicron is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.AlcoaSource: Daniel J. Macy / Shutterstock.comAlcoa produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.NutrienSource: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like Nutrien, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.American International GroupSource: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.3MSource: r.classen / Shutterstock.com3M produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.MicrosoftSource: The Art of Pics / Shutterstock.comWhen 2022 began, Microsoft stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.PfizerSource: photobyphm / Shutterstock.comPfizer received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9025134314,"gmtCreate":1653635557638,"gmtModify":1676535318911,"author":{"id":"3571044771112848","authorId":"3571044771112848","name":"ming22","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3571044771112848","authorIdStr":"3571044771112848"},"htmlText":"Good, time to dca&nbsp;","listText":"Good, time to dca&nbsp;","text":"Good, time to dca","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9025134314","repostId":1154795776,"repostType":2,"repost":{"id":"1154795776","pubTimestamp":1653628057,"share":"https://ttm.financial/m/news/1154795776?lang=&edition=fundamental","pubTime":"2022-05-27 13:07","market":"us","language":"en","title":"7 Undervalued Blue-Chip Stocks to Buy for June","url":"https://stock-news.laohu8.com/highlight/detail?id=1154795776","media":"InvestorPlace","summary":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock","content":"<html><head></head><body>These undervalued blue-chip stocks possess excellent long-term potential.<ul><li><a href=\"https://laohu8.com/S/MU\">Micron</a>: Semiconductor stock that blends growth and low valuation.</li><li><a href=\"https://laohu8.com/S/AA\">Alcoa</a>: Net income growth bodes very well for the commodities giant.</li><li><a href=\"https://laohu8.com/S/NTR\">Nutrien</a>: The undervalued Canadian firm is vital to food production.</li><li><a href=\"https://laohu8.com/S/AIG\">American International Group</a>: AIG’s upside is attractive and its staid dividend smooths current volatility.</li><li><a href=\"https://laohu8.com/S/MMM\">3M</a>: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.</li><li><a href=\"https://laohu8.com/S/MSFT\">Microsoft</a>: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.</li><li><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>: Vaccine sales will fuel future growth, making Pfizer noteworthy.</li></ul>With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.<a href=\"https://laohu8.com/S/MU\">Micron</a><img src=\"https://static.tigerbbs.com/d789740a0d55698fce2eaa27ff334fcb\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Charles Knowles / Shutterstock.com<a href=\"https://laohu8.com/S/MU\">Micron</a> is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.<a href=\"https://laohu8.com/S/AA\">Alcoa</a><img src=\"https://static.tigerbbs.com/345c732c89a6bd214adff72fe56d3249\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Daniel J. Macy / Shutterstock.com<a href=\"https://laohu8.com/S/AA\">Alcoa</a> produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.<a href=\"https://laohu8.com/S/NTR\">Nutrien</a><img src=\"https://static.tigerbbs.com/cf261f41b67b978b2bccc50b86f9619b\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like <a href=\"https://laohu8.com/S/NTR\">Nutrien</a>, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.<a href=\"https://laohu8.com/S/AIG\">American International Group</a><img src=\"https://static.tigerbbs.com/4fbf6ee441b7aaaccd4fbe0cf78bfd2a\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.<a href=\"https://laohu8.com/S/MMM\">3M</a><img src=\"https://static.tigerbbs.com/dcfdc62e0b1977b35e871a578f6f8388\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: r.classen / Shutterstock.com<a href=\"https://laohu8.com/S/MMM\">3M</a> produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.<a href=\"https://laohu8.com/S/MSFT\">Microsoft</a><img src=\"https://static.tigerbbs.com/998767af9244c24d2eca1a6c74ee6b60\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: The Art of Pics / Shutterstock.comWhen 2022 began, <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.<a href=\"https://laohu8.com/S/PFE\">Pfizer</a><img src=\"https://static.tigerbbs.com/24582c18e5505b72fa27f4466b6dc4db\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: photobyphm / Shutterstock.com<a href=\"https://laohu8.com/S/PFE\">Pfizer</a> received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Undervalued Blue-Chip Stocks to Buy for June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Undervalued Blue-Chip Stocks to Buy for June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-27 13:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nThese undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities ...\n\n<a href=\"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NTR":"Nutrien Ltd.","MSFT":"微软","MMM":"3M","AIG":"美国国际集团","MU":"美光科技","AA":"美国铝业"},"source_url":"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154795776","content_text":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities giant.Nutrien: The undervalued Canadian firm is vital to food production.American International Group: AIG’s upside is attractive and its staid dividend smooths current volatility.3M: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.Microsoft: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.Pfizer: Vaccine sales will fuel future growth, making Pfizer noteworthy.With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.MicronSource: Charles Knowles / Shutterstock.comMicron is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.AlcoaSource: Daniel J. Macy / Shutterstock.comAlcoa produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.NutrienSource: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like Nutrien, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.American International GroupSource: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.3MSource: r.classen / Shutterstock.com3M produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.MicrosoftSource: The Art of Pics / Shutterstock.comWhen 2022 began, Microsoft stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.PfizerSource: photobyphm / Shutterstock.comPfizer received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9025132405,"gmtCreate":1653635312007,"gmtModify":1676535318880,"author":{"id":"4090216573849900","authorId":"4090216573849900","name":"HL Chua","avatar":"https://community-static.tradeup.com/news/f6e5a20bb17d784ba2fdaca67b3e5a65","vip":1,"hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","crmLevel":9,"crmLevelSwitch":1,"idStr":"4090216573849900","authorIdStr":"4090216573849900"},"htmlText":"All expensive stocks to me","listText":"All expensive stocks to me","text":"All expensive stocks to me","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9025132405","repostId":1154795776,"repostType":2,"repost":{"id":"1154795776","pubTimestamp":1653628057,"share":"https://ttm.financial/m/news/1154795776?lang=&edition=fundamental","pubTime":"2022-05-27 13:07","market":"us","language":"en","title":"7 Undervalued Blue-Chip Stocks to Buy for June","url":"https://stock-news.laohu8.com/highlight/detail?id=1154795776","media":"InvestorPlace","summary":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock","content":"<html><head></head><body>These undervalued blue-chip stocks possess excellent long-term potential.<ul><li><a href=\"https://laohu8.com/S/MU\">Micron</a>: Semiconductor stock that blends growth and low valuation.</li><li><a href=\"https://laohu8.com/S/AA\">Alcoa</a>: Net income growth bodes very well for the commodities giant.</li><li><a href=\"https://laohu8.com/S/NTR\">Nutrien</a>: The undervalued Canadian firm is vital to food production.</li><li><a href=\"https://laohu8.com/S/AIG\">American International Group</a>: AIG’s upside is attractive and its staid dividend smooths current volatility.</li><li><a href=\"https://laohu8.com/S/MMM\">3M</a>: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.</li><li><a href=\"https://laohu8.com/S/MSFT\">Microsoft</a>: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.</li><li><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>: Vaccine sales will fuel future growth, making Pfizer noteworthy.</li></ul>With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.<a href=\"https://laohu8.com/S/MU\">Micron</a><img src=\"https://static.tigerbbs.com/d789740a0d55698fce2eaa27ff334fcb\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Charles Knowles / Shutterstock.com<a href=\"https://laohu8.com/S/MU\">Micron</a> is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.<a href=\"https://laohu8.com/S/AA\">Alcoa</a><img src=\"https://static.tigerbbs.com/345c732c89a6bd214adff72fe56d3249\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Daniel J. Macy / Shutterstock.com<a href=\"https://laohu8.com/S/AA\">Alcoa</a> produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.<a href=\"https://laohu8.com/S/NTR\">Nutrien</a><img src=\"https://static.tigerbbs.com/cf261f41b67b978b2bccc50b86f9619b\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like <a href=\"https://laohu8.com/S/NTR\">Nutrien</a>, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.<a href=\"https://laohu8.com/S/AIG\">American International Group</a><img src=\"https://static.tigerbbs.com/4fbf6ee441b7aaaccd4fbe0cf78bfd2a\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.<a href=\"https://laohu8.com/S/MMM\">3M</a><img src=\"https://static.tigerbbs.com/dcfdc62e0b1977b35e871a578f6f8388\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: r.classen / Shutterstock.com<a href=\"https://laohu8.com/S/MMM\">3M</a> produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.<a href=\"https://laohu8.com/S/MSFT\">Microsoft</a><img src=\"https://static.tigerbbs.com/998767af9244c24d2eca1a6c74ee6b60\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: The Art of Pics / Shutterstock.comWhen 2022 began, <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.<a href=\"https://laohu8.com/S/PFE\">Pfizer</a><img src=\"https://static.tigerbbs.com/24582c18e5505b72fa27f4466b6dc4db\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/>Source: photobyphm / Shutterstock.com<a href=\"https://laohu8.com/S/PFE\">Pfizer</a> received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Undervalued Blue-Chip Stocks to Buy for June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Undervalued Blue-Chip Stocks to Buy for June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-27 13:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nThese undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities ...\n\n<a href=\"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NTR":"Nutrien Ltd.","MSFT":"微软","MMM":"3M","AIG":"美国国际集团","MU":"美光科技","AA":"美国铝业"},"source_url":"https://investorplace.com/2022/05/7-undervalued-blue-chip-stocks-to-buy-for-june/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154795776","content_text":"These undervalued blue-chip stocks possess excellent long-term potential.Micron: Semiconductor stock that blends growth and low valuation.Alcoa: Net income growth bodes very well for the commodities giant.Nutrien: The undervalued Canadian firm is vital to food production.American International Group: AIG’s upside is attractive and its staid dividend smooths current volatility.3M: Four straight earnings beats suggest 3M will remain strong, and it’s cheap now.Microsoft: Microsoft continues to perform exceptionally well, but it’s discounted despite its overwhelming buy status.Pfizer: Vaccine sales will fuel future growth, making Pfizer noteworthy.With the ongoing market correction, there are bound to be multiple undervalued blue-chip stocks for sale at excellent prices. For investors who’ve long held positions in these equities, the correction is troublesome. Gains have been erased. Of course, one investor’s loss is often another’s gain — and right now is a strong time to pick up blue-chip stocks while they remain undervalued.These stocks are household names and trade with massive market capitalizations. They’re usually industry leaders and often the biggest player in their respective sectors. They boast dependable earnings, substantial operating histories and often pay dividends as well.With that said, let’s look at the best deals among undervalued blue-chip stocks to buy in June.MicronSource: Charles Knowles / Shutterstock.comMicron is a U.S.-based semiconductor company that often fails to garner as much attention as similar firms. That said, there’s plenty to appreciate about it. It makes DRAM, NAND, and NOR memory and storage technology, but is rarely mentioned alongside AMD or Nvidia.That said, MU stock is very much worth considering right now. High-level metrics clearly suggest there’s massive upside in it at current prices. The equity boasts an averagetarget stock priceof $111.45 but can be purchased for under $70 currently.The reason it’s worth considering is that MU stock is slated to grow as measured by net income while likely increasing its dividend. All the while, it remains cheap based on price-to-earnings (P/E) ratio.Its8.5x P/E ratiois well below the 19.16x average across the semiconductor industry. If you want bottom-line growth at a cheap price, Micron is absolutely worth picking up.AlcoaSource: Daniel J. Macy / Shutterstock.comAlcoa produces bauxite, alumina and aluminum products. Its business is mundane and by most standards, it isn’t likely to excite investors on that alone. However, the upside in AA stock should.It is trading lower over the past few weeks, but it hasn’t lost value overall in 2022. Yes, it possesses upside based on consensus analyst prices. Those estimates suggest a potential increase of nearly 50% at AA stock’s current price.The reason investors should believe share prices can rise quickly lies in the bottom-line growth predicted for the firm. In 2021, Alcoa’s $12.2 billion in revenue led to a net income of $429 million.In 2022, that revenue isanticipated to increaseby more than 18% to $14.4 billion. That’s nice enough growth, but what really should impress is the notion that Alcoa’s net income is expected to nearly quintuple at the same time. The company’s net income is expected to reach $2.1 billion in 2022.NutrienSource: Pavel Kapysh/ShutterStock.comIt’s hard to read about markets and not come across a headline about the increasing value of food production and cropland. They imply companies like Nutrien, which produces potash, nitrogen and phosphate, will have more importance moving forward.Increasing food production will require more land under cultivation, which in turn requires more fertilizer use that includes the products Nutrien produces. That’s the underlying macroeconomic argument that favors the company.The fundamental argument that favors NTR stock is its valuation relative to its peers. The firm’s 13x P/E ratio is slightly lower than the industry median of 15.1x. That is wildly lower than its industry, which is a positive. Stocks that are severely undervalued often suffer due to factors outside of what their fundamentals can explain. In other words, Nutrien is not a value trap.The company is growing following recordfirst-quarter earningsof $1.4 billion. Both revenue and profit are expected to continue to surge as the Canadian firm responds to fill the void created by the ongoing war in Ukraine.American International GroupSource: Evan El-Amin / ShutterstockThe insurance industry is not an exciting business. Therefore, it is to be expected that insurance stocks carry low valuation metrics. That said,AIG(NYSE:AIG) stands out among its peers in terms of value.The stock’s P/E ratio of 5.8x is roughly half that of the industry overall, which sits at 10.7x. That doesn’t tell us much, because the market could simply prefer an average insurance firm to AIG. If that were the case, then its much lower valuation wouldn’t be an opportunity.But it is an opportunity because AIG stock’s median P/E ratio over the last 10 years is 9.85x. That strongly implies once we exit the current market — whenever that may be — then AIG stock should fare much, much better.When that capital returns, share prices will rise. Until then, current investors also have a modest and reliable dividend yielding 2.3% to look forward to.3MSource: r.classen / Shutterstock.com3M produces a lot of products — in fact,more than 60,000of them. So it’s almost inevitable that you’ve used one or more of them in the past. But it isn’t the breadth of product offerings that makes MMM stock interesting to value investors as much as current prices.3M shares began 2022 trading around $180. However, they’ve fallen to a range between $140 and $150 as of early February. They’ve since struggled to escape that range.But there’s reason to remain enthusiastic about the firm’s prospects. For one, it has exceeded analyst expectations in each of the past four quarters and provided earnings beats. And each of those four quarters has exceeded the high points of analyst ranges.Onevaluationsuggests MMM stock should trade at $186.80 based on several historic multiples.MicrosoftSource: The Art of Pics / Shutterstock.comWhen 2022 began, Microsoft stock was trading at $335. That wasn’t far from its target stock price of $360. So it would have been much harder to proffer the idea that there was massive upside in it back then.That was also before inflation was the dominant issue it now is, and the tech wreck hadn’t yet done much damage. Fast forward a few months and the story is vastly different. Microsoft shares trade near $250. However, analysts remain steadfast, with the overwhelming majority rating it a buy.Microsoft continues to perform amazingly well, though. Its most recentearningsshowed that revenues increased 18%, reaching $49.4 billion in the quarter. I could go on and on about Microsoft’s impressive results, but the point is that when the market offers MSFT stock cheap, buying just makes sense.PfizerSource: photobyphm / Shutterstock.comPfizer received a modest bump on May 20 when it was announced that the Centers for Disease Control and Prevention (CDC) hadcleared its boosterfor use in children ages 5 to 11. While that news indicates a new revenue stream for the company, its prospects moving forward are less about Covid-19 vaccines and more about leveraging the proceeds from that business.Investors believe Pfizer is losing its sheen as the pandemic enters its later stages. PFE stock has lost about 5% of its value year-to-date. But it was one of the winners in the race to develop a vaccine for Covid-19. That ensures the company has money to develop and acquire future potential blockbuster drugs.It’s now cheap, well-funded and in position to remain so for the long term.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":195,"commentSize":49,"repostSize":0,"favoriteSize":7,"likeStatus":false,"favoriteStatus":false}}